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Small, cysteine-rich proteins called metallothioneins (MTs) bind essential divalent heavy 
metal cations, such as zinc and copper, as well as toxic heavy metals, such as cadmium 
and mercury.   Stressful conditions such as exposure to heavy metals or reactive oxygen 
species (ROS) increase the expression of MTs.  The numerous cysteine residues in MTs 
allow the protein to neutralize toxic effects of ROS, bind heavy metals, influence immune 
cell movement and proliferation.  The bacteria Pseudomonas aeruginosa expresses an 
MT, PmtA, that is similar in structure the eukaryotic MTs. Evidence presented in these 
suggests that PmtA is an immunomodulatory protein, similar to the eukaryotic 
counterpart.  Jurkat T cells pre-incubated with PmtA and subsequently exposed to a 
gradient of SDF-1α, lost the ability to move in a persistent direction, while Jurkat T cells 
pre-incubated with GST did respond to the SDF-1α gradient.  Incubation with PmtA also 
decreased SDF-1α-induced internalization of the receptor CXCR4 on Jurkat T cells.  P. 
aeruginosa strain PW4670 lacks PmtA expression, and is also more sensitive to oxidant 
exposure than the parent strain PA01.  PW4670 also fails to produce pyocyanin, a 
secondary metabolite that produces ROS that can disrupts the immune response to P. 
aeruginosa.  Due to the lack of pyocyanin by PW4670, PAO1 supernatant is more likely 
to kill macrophage cells in vitro and Galleria mellonella larvae in vivo, that PW4670 
supernatant.  Taken together, these results suggest that the expression of PmtA influences 
the virulence of P. aeruginosa, and may be a novel target for therapeutic intervention. 
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CHAPTER 1: BACKGROUND AND SIGNIFICANCE 
 
1 Introduction  
 
 Metallothioneins (MTs) are a family of low molecular weight, cysteine-rich 
proteins.  MTs were first identified in mammals due to their metal binding capacity [1].  
Extensive research on MTs has revealed that these proteins possess several diverse 
functions from acting as a reservoir for essential metals to influencing the cellular redox 
environment and immune cell functions.  MTs are not essential to life, as viable MT-
knockout mouse models have been constructed, but evidence shows that the expression 
of MT is advantageous to animals exposed to stressful conditions.  The majority of this 
research focuses on eukaryotic forms of MTs from small mammals such as mice and 
rabbits.  Research that involves MTs from other species is not as extensive as the research 
in mammalian MTs.  
  The human pathogen Pseudomonas aeruginosa expresses a small molecular 
weight, cysteine rich MT, referred to as PmtA.  Aside from its metal binding capacity, 
very little research has been done on this protein’s functions in P. aeruginosa.  If PmtA 
acts similarly to mammalian MT and enhances survival of the organism in stressful 
conditions through several multifunctional roles, PmtA may influence the progression of 
infection and overall virulence of the pathogen.   
 The focus of this study is to determine if PmtA modifies the mammalian immune 
response in a similar manner as its eukaryotic counterparts, with a focus on the 
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chemotactic and redox sensitive properties of PmtA.  The chemotactic model uses a GST-
PmtA purified from Escherichia coli expressing the pGEX-6p-PmtA plasmid.  The 
movement of Jurkat T cells was measured after exposure to the purified GST-PmtA.  
PmtA’s function in the presence of oxidative stress was determined with a P. aeruginosa 
strain that lacked the expression of a functional PmtA protein.  This study determined 
that PmtA alters the chemotactic response of host immune cell and influences the 
expression of P. aeruginosa virulence factors. 
 
1.1 Stress and Immunity  
Exposure to acute or chronic stressors intensify symptoms of many inflammatory 
disease states such as multiple sclerosis [2, 3], irritable bowel syndrome [4, 5] diabetes 
[6] and cardiovascular disease [7].    External stressors include elevated temperature, 
bacterial infection, exposure to toxins, toxicants, metals and reactive oxygen and 
nitrogen species.  Stressors can be psychological, physical, or chemical and impact the 
other functions of the immune system through the activation of an inflammatory 
response.  This leaves patients susceptible to the aforementioned inflammatory disease 
states as well as bacterial infection [8].  
Psychological stressors impact the overall efficiency of the immune response by 
altering cytokine and cortisol expression.   A change in the cytokine profile of an 
organism alters its immune response to pathogens and can intensify symptoms of 
inflammatory disease states.  For example, chronic work stress elevates and sustains 
levels of the pro-inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor-
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α (TNF-α)  [9, 10].  An increase in pro-inflammatory cytokines can disrupt the Th1/Th2 
cell balance and worsen inflammatory disease states.  The change in cytokine expression 
associated with psychological stressors such as, anxiety or depression can modify the T 
cell response to anti-viral vaccines against hepatitis B virus and rubella virus [11, 12].  
Change in the cytokine profile of accompanying social stressors can decrease the 
microbial intestinal diversity in the mice and leave them susceptible to intestinal 
inflammation [13].  Psychological stressors in mice also alter the kinetics of an antibody 
response to the influenza virus and the ability of immune cells to traffic to the site of 
infection [14].   
Chemical stressors like ROS alter redox-sensitive signaling in immune cells, 
which interrupts signal transduction and subsequently changes cytokine expression [15].  
ROS production by immune cells is necessary, as it allows immune cells to kill invading 
pathogens.  However, excessive ROS production can cause apoptosis of host cells and 
alter cytokine profiles of organism in ways that are not advantageous to the host.   
Cells attempt to counteract the profound affects of psychological, chemical and 
biological stressors on the immune response and other cellular functions through the 
expression of stress response proteins [16]. 
 
1.2 Cellular Stress and Stress Response Proteins 
 In response to the changes in extracellular stimuli brought on though exposure to 
stress, cells induce a stress response.  This response allows the cell to repair damage and 
adapt to the new environment, or triggers apoptosis and autophagy [17].  In general, the 
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cellular stress response alters expression of certain proteins to protect against cellular 
damage.   
A well-studied family of stress response proteins is the heat shock proteins 
(HSPs).  The high degree of evolutionary conservation among HSPs highlights 
importance of these proteins to the survival of cells.  As their name would suggest, HSPs 
were first identified in cells that were exposed to high temperatures, or heat shock.  Many 
other potentially damaging stressors such as ROS, hypoxia, heavy metal stress, glucose 
deprivation, and microbial infection all induce expression of HSPs [18].  The numerous 
HSPs expressed in mammals are categorized by molecular weight, therefore HSP70 and 
HSP90 are 70 and 90 kilodaltons, respectively [19].  In the absence of stress, cells 
express HSPs at low levels, the onset of stress forces the cell to upregulate expression of 
these proteins to maintain homeostasis [20].   
Expression of HSPs can profoundly affect the immune response to pathogens and 
tumor cells.   Upon increase in HSP expression, HSPs are broken into peptides presented 
on major histocompatibility complex (MHC) class I.  Presentation on MHCI activates 
cytotoxic T cells (CTLs) [21] and increases CTL-mediated killing of virally infected cells 
[22].  Through this same mechanism, HSPs can be presented on the MHCI of tumor cells 
and induce CTL-mediated killing tumor cells [23-25].  In mice, CTL-mediated killing of 
tumor cells often lyses the cells and subsequently immunizes the animals against the 
tumor [25-27].  HSPs can also act as chaperone proteins that carry antigenic peptides [23, 
28], which can be readily phagocytized by APC’s and eventually presented to CD4+ T 
cells on MHCII [27].  Phagocytosis of these HSP-peptide complexes also induce 
macrophage expression of proinflammatory cytokines IL-1β, TNFα, IL-12, GM-CSF and 
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the chemokines MCP-1, MIP-1, RANTES and promotes the inflammatory response 
against a pathogen [29, 30].  These changes in expression will affect immune cell 
activation, signaling and chemotaxis [27].   
 
1.3 The Stress Response Protein Metallothionein 
The stress response protein metallothionein (MT) is a small molecular weight, 
cysteine rich protein.  MT uses sulfhydryl groups present on cysteine residues to bind 
toxic and essential heavy metals and to neutralize ROS [31].  In the absence of cellular 
stress, MT acts as a reservoir for essential heavy metals such as zinc and copper [32].  
MT donates these metals to apoenzymes and zinc-finger transcription factors that require 
these essential metals to function [33].   MT maintains homeostasis of essential heavy 
metals through the redistribution of the metals to different parts of the cell [34].   MT in a 
zinc bound state is very stable which makes it an ideal reservoir for intracellular zinc 
[35]. 
Under cellular stress from toxic heavy metals, such as cadmium and mercury, the 
cell increases MT expression.  MT releases some essential metals in order to sequester 
toxic heavy metals and prevent these metals from damaging the cell [36].  MT expression 
also increases in the presence of ROS. The thiol groups on MT become oxidized to 
prevent ROS from oxidizing other parts of the cell.   
Protection from ROS is vital to cells as the oxidation of cellular components can 
lead to cellular damage and inflammatory disease.  For example, in rheumatoid arthritis 
(RA) neutrophils, macrophages, and lymphocytes infiltrate the synovium and cause 
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persistent inflammation [37-39].  Once in the synovium macrophages and neutrophils 
produce ROS through oxidative bursts.  The resulting ROS can oxidize polyunsaturated 
fatty acids of the membrane lipids, a process called lipid peroxidation [38].  Lipid 
peroxidation damages the membranes of cells and causes persistent inflammation in the 
joints [40, 41].  As evidenced from the role of oxidation in the pathogenesis of RA, 
defenses against cellular oxidation are necessary to maintain redox homeostasis within 
the cell.  In the collagen-induced arthritis murine model of RA injection of MT reduced 
the severity of the disease [42].  MT may be able to become oxidized and decrease the 
oxidation of lipids in the arthritic mouse.  However, injection of MT also decreases 
proinflammatory mediators, which in turn can decrease the expansion of 
proinflammatory, ROS-producing cells in the arthritic mouse [42].   
 
1.3.1 Classes of Metallothioneins 
 Proteins in several different organisms are classified as MTs due to their 
extremely high metal and sulfur content.  All of these proteins are low molecular weight 
proteins with a high number of cysteine residues, which are associated with their ability 
to bind metals [1].  Previously, the classification as an MT did not include any protein 
with aromatic amino acids, however, more recently bacterial proteins that utilize both 
cysteine and histidine residues in their metal binding functions have been classified as 
MTs [1, 43, 44].  Aromatic amino acids can bind metals and influence cellular redox 
status.  Therefore, it is not expected that the presence of aromatic amino acids changes 
the function of these MTs [45]. 
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In mammals, MTs are categorized into 4 major classes: MT-I, -II, -III, and -IV.  
In humans these genes map onto chromosome 16 [46], and in mice MT genes are located 
on chromosome 8 [47].  The MT-III and –IV genes encode for single isoforms of these 
proteins, while MT-I and MT-II have several different isoforms that tend to be expressed 
in specific cell types [48].  MT-I and MT-II are expressed in all types of tissues, while 
MT-III and MT-IV are more, but not exclusively, tissue specific [48]. 
 The functional differences between MT-I and MT-II have not been elucidated 
because a single knockout mouse model has not been constructed.  MT-I and MT-II are 
highly homologous and difficult to chemically separate. MT murine models consist of 
MT-I and MT-II double knockouts, as well as MT-I transgenic models [48].  MT-I and 
MT-II double knockout mice are more susceptible to heavy metal stress and oxidation by 
ROS.  The inflammatory response and immune response to infection also differ in MT-I, 
-II, double knockout mice when compared to wild type mice [49].  
 Heavy metals induce expression of MT-I and II, however, that is not the case with 
MT-III [50].  MT-III first called growth inhibitory factor (GIF), is also a small molecular 
weight, high cysteine protein that is known to bind both copper and zinc.  MT-III was 
originally defined as GIF because it inhibited the growth of neuronal cells in vitro.  The 
genes that encode MT-III are found in the same gene cluster as MT-I and MT-II in both 
humans and mice and share 65% homology with MT-I genes [50].  
 The MT-IV gene lies 20kb from the 5’ end of the MT-III gene in humans and 
mice and is highly conserved in both species.  Expression of MT-IV is limited to the 
stratified squamous epithelia [51].  In situ experiments that label MT-IV mRNA show 
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that MT-IV expression dominates in the differentiating spinous layer of the epithelia, 
while MT-I expression increases in the basal, proliferating layer of epithelium. This 
suggests that a switch in the MT isoform expression is necessary during the 
differentiation of epithelia [51].   
 
1.4 MT and immunity  
 A very interesting aspect of MT is its influence on immune cell function.  Tissues 
vital to the development of an immune response, such as mammalian fetal liver and 
neonatal thymus, express MT at very high levels [52].  MT can be found on the surface of 
leukocytes in culture exposed to mitogen or exogenous MT, which suggests that 
leukocytes may express a receptor for MT [53-55]. 
 Another immunomodulatory function of MT is its effects on the proliferation and 
function of T and B cells.  The combination of MT and Concanvlin A (Con A) stimulates 
proliferation of T cells more than just Con A alone [53, 56].  Similarly, MT increases 
proliferation of B cells in the presence of the polyclonal B cell activator, 
lipopolysaccharide (LPS) [53].  MT also affects the antibody response by B cells to an 
antigen.  MT decreases the anti-ovalbumin production in mice co-immunized with MT 
and ovalbumin compared to injection with ovalbumin alone. The addition of UC1MT, a 
monoclonal MT-specific antibody, reverses this immunosuppression [57].  Apo-MT, 
which lacks association with metals and has a decrease in free thiols due to oxidation, 
fails to change the anti-ovalbumin level in immunized mice, which indicates the thiols on 
MT are vital to MT’s immunosuppressive effects [57].  MT-I and MT-II double knockout 
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mice mount a vigorous T-cell dependent humoral response when compared to their 
wildtype counter parts, which further supports the hypothesis that MT is 
immunosuppressive [54]. 
 MT affects cells that contribute to the cell-mediated immune response differently 
than their humoral immune counterparts.  The phagocytic capacity of macrophages does 
not change with exposure to MT, but MT-exposed macrophages do increase the 
production of ROS.  This increase in ROS may contribute to MT-exposed macrophages 
superior ability to kill Candida albicans when compared to macrophages that are not 
exposed to exogenous MT [55].  MT can be detected on the cell surface of MT-exposed 
macrophages, which again could suggest the existence of an MT cell surface receptor 
[55]. 
MT gene dose impacts the ability of mice to eliminate Listeria monocytogenes 
infections, measured by bacterial burden in both the liver and spleen of infected animals.  
MT knockout and MT transgenic mice were better able to clear the pathogen 3 days post-
inoculation than their wildtype counterparts.  However, death of lymphocytes was 
increased in infected MT knockout mice, perhaps due to the increase in oxidant measured 
in both knockout and transgenic mice compared to wildtype mice [49].  The effect of MT 
gene dose on the progression of infection supports the hypothesis that MT is an 
immunomodulatory protein. 
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1.5 Reactive Oxygen Species 
 Reactive oxygen species (ROS)  are oxygen species that contain unpaired valence 
electrons. These valance electrons make ROS highly reactive and able to cause cellular 
damage. [58].  Normal aerobic metabolic processes can produce ROS in the mitochondria 
and peroxisomes.  Some ROS, such as hydrogen peroxide (H2O2), pass through 
membranes and can cause damage to intracellular components including the nucleus [58].  
Cells express stress response proteins that defend against ROS, like MT and the 
antioxidant enzyme catalase.  However, a large amount of endogenous or exogenous 
ROS can overwhelm antioxidant defenses in the cell and cause oxidative damage.   ROS 
target cellular components such as nucleic acids, proteins and lipids [15, 59, 60].  
Oxidative damage to nucleic acids, proteins and lipids can alter the structure and function 
of these components and disrupt cell signaling.  Disruption of cell signaling as a result of 
ROS-induced damage can lead to the development of several disorders, such as diabetes 
[61, 62], atherosclerosis  [63], rheumatoid arthritis [64, 65], Parkinson’s disease [66, 67] 
and cancer [68].  
 The production of ROS during aerobic respiration is unavoidable so aerobic 
organisms have developed antioxidant mechanisms to detoxify ROS.  As the most 
abundant intracellular antioxidant, the peptide glutathione provides cells with protection 
against ROS.  The amino acids cysteine, glutamic acid, and glycine comprise glutathione.  
Much like MT, the cysteine thiol of glutathione serves as the active group [69].  
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All mammalian organs and tissues express glutathione.  In the absence of 
oxidative stress, glutathione is mainly in its reduced form, GSH.  Under oxidative stress, 
GSH is oxidized to GSSG.  The enzyme glutathione reductase then reduces GSSG back 
to GSH. [69]  The redox environment of the cell can be determined by the ratio of GSH 
to GSSG [70].  
 Mammalian cells also contain mechanisms to produce ROS.  Professional 
phagocytic cells, such as antigen presenting cells (APCs), produce ROS in order to 
damage bacterial cells and thus can eliminate infections.  Polymorphonuclear neutrophils 
(PMNs) and macrophages engulf infiltrating bacteria into intracellular vesicles called 
phagosomes, which release an oxidative burst [71].  This release of oxygen aims to kill 
the bacteria contained within the phagosome, but it can also change the overall redox 
potential of the cell, which affects cell signaling.  The cytosolic H2O2 that results from an 
oxidative burst in the phagosome inactivates tyrosine phosphatases and activates tyrosine 
kinases through oxidation of cysteine thiol groups [72].  The majority of the H2O2 in the 
cytosol is produced by NADPH oxidase.  
 
1.5.1 NADPH oxidase 
 As a member of the NOX family transmembrane electron transport system, 
NADPH oxidase is responsible for the generation of extracellular superoxide released 
from phagocytes as well as intracellular oxidative bursts in phagosomes [73].  It is a 
membrane-associated enzyme that catalyzes the production of superoxide anion (O2-). 
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NADPH oxidase activates through the phosphorylation of the cytosolic NADPH 
subunit p47phox and subsequent interaction with the p22phox subunit, which causes 
membrane translocation of p47phox.  The membrane translocation of p47phox then allows 
for the assembly of other cytoplasmic subunits, and the formation of the complete, and 
active, NADPH complex [74]. The NADPH complex transports electrons from the 
cytoplasmic portion of NADPH to extracellular oxygen, as well as phagosomal oxygen 
[75].  This generates superoxide (O2-), which serves as a precursor to other ROS, such as 
singlet oxygen, hypochlorous acid (HOCl) and H2O2 [76].    
 The clearance of pathogens often depends on the production of ROS by NADPH 
oxidase.  In 1957 two patients were identified as suffering from constant infections 
accompanied by granulomas, swollen lymph nodes and hypergammaglobulinemia [77].   
Their condition became known as Chronic Granulomatous Disease (CGD) and the 
symptoms were attributed to the lack of the protein cytochrome b558, which is essential to 
the function of NADPH oxidase [78, 79].  The phagocytes of CGD patients fail to 
produce ROS and cannot successfully clear many microbial infections [80-82].  
On the opposite end of the spectrum, over activation of NOX family of NADPH 
oxidases, such as NOX2, can also cause complications.  Activation of NOX2 NADPH 
oxidases requires signals from protein kinase C (PKC) activators, microbial components, 
G-protein coupled receptor (GPCR) agonists or chemotactic peptides [83].  However, 
NOX2 can be chronically active without these signals and causes localized oxidative 
stress.  This localized oxidative stress due to chronic activation of NOX2 has been 
associated with the inflammation in the joints of RA patients in inflamed tissues [84].  In 
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RA, over activation of NOX2 overwhelms host antioxidant defenses and causes 
peroxidation of lipids.  This leads to the localized joint inflammation [84].   
 
1.5.2 Superoxide 
The initial oxidant produced by NADPH oxidase and released in the oxidative 
burst is superoxide (O2-) [85].  Superoxide reacts with cysteine residues on proteins, 
oxidizing thiol groups [86]. NADPH oxidase generates superoxide in the following 
reaction [75]:  
NADPH + 2O2  NADP+ + 2O2- + H+ 
Although superoxide is the initial oxidant produced, it is a relatively weak anti-microbial 
[87-89], and therefore does not directly kill bacteria.  Superoxide dismutase rapidly 
converts superoxide into H2O2, which can then kill bacteria or further react with 
superoxide to form other ROS, such as singlet oxygen or hydroxyl radicals that are toxic 
to bacteria [75].  
 
1.5.3.Hydrogen peroxide 
Release of superoxide in an oxidative burst quickly lends itself to the production 
of H2O2 in the following reaction: 
O2-+ O2- +2H+  H2O2 + O2 
[90]. 
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 The formation of H2O2 can be spontaneous, catalyzed by the enzyme superoxide 
dismutase, or a produced as a byproduct of mitochondrial respiration [91].  H2O2 carries a 
high reduction potential and serves as a strong oxidizer, which contribute to its strong 
anti-microbial response.   
 
1.5.4 ROS Signaling   
ROS affect cellular signaling through two major mechanisms; the oxidative 
modification of proteins and the alteration of cellular redox state and [15]. ROS influence 
cellular signal transduction through the oxidation and subsequent inactivation of enzymes 
that utilize cysteine residues at their active site, such as, protein tyrosine phosphatase 
(PTPs) [92-96]. ROS modification renders the protein non-functional and disrupts 
signaling downstream from the modified protein.  In the absence of oxidative stress, the 
cell maintains the cytosol in a reduced state with the help of intracellular antioxidants, 
such as GSH.  However, if oxidant overwhelms GSH buffering capacity the level of GSH 
decreases as it is quickly oxidized into GSSG.  When GSH buffering capacity is 
overwhelmed, the redox status begins to affect cell fate.  For example, a decrease in GSH 
can increase proliferation of fibroblasts [97].  The fibroblast mitogen PDGF relies on 
GSH to regulate its activity, as reduction of PDGF renders the mitogen inactive.  A 
decrease in GSH is associated with an increase in PDGF activity, which may lead to the 
increase in fibroblast proliferation [97].   An increase in intracellular thiols partially 
reverses these proliferative effects, which indicates the maintenance of the intracellular 
redox environment is essential to the regulation of fibroblast proliferation [98].  ROS can 
also modify critical amino acids of a protein and change the function of the protein.  
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Oxidation of the –SH group on a cysteine residue of an enzyme can physically alter the 
activity of an enzyme, and thus its function [15].  The redox status of the cell therefore 
regulates the functions of thiol-rich proteins.  For example, oxidation of HSP33 forces the 
formation of a disulfide bond.  This signals HSP33 to dimerize and function as a 
chaperone [99, 100].  Regulation of redox sensitive thiol rich proteins requires reduction 
of these thiol groups by intracellular antioxidants like GSH, thioredoxin and thioredoxin 
reductase [101, 102].  
Release of ROS in a defensive oxidative burst can also affect the signal 
transduction of the infiltrating bacteria.  Oxidation causes the redox-sensitive bacterial 
transcription factor OxyR to activate and bind DNA through the formation of a disulfide 
bond within the transcription factor [103, 104]. This induces the expression of various 
gene products that combat oxidative damage, including katG, which encodes a hydrogen 
peroxidase that neutralizes the harmful effects of H2O2 [105] 
 
1.5.5 MT and ROS  
Cells increase the expression of MT in the presence of oxidative stress [106].  
Under oxidative stress the –SH groups on MT can become oxidized and protect the host 
cell from damage.  Oxidation of MT’s thiols also affects the intracellular free zinc 
concentration [107]. In order for MT to become oxidized, it must have free thiol groups, 
which means it cannot be saturated by zinc.  Under oxidative conditions MT releases 
bound zinc, and becomes oxidized by ROS [108]. This couples redox signaling and zinc 
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homeostasis [35].  As oxidized MT reduces, it regains the ability to bind zinc, and once 
again becomes a reservoir for the essential heavy metal.  
 
1.5.6 Assessing ROS  
 The assessment of ROS within a cell relies on the measurement of oxidative 
products.  The ratio of GSH to GSSG indicates the level of oxidative stress since GSSG 
should be continuously regenerated by a NADPH-dependent reductase [109] GSH and 
GSSG concentrations can be determined biochemically or with HPLC [110].  
 Measurement of lipid peroxidation is a common assessment of oxidative stress. 
Free radicals target hydrogen on unsaturated fatty acids to form water and a lipid 
peroxide [111].  The unstable lipid peroxides then break down to form carbonyl 
compounds such as malondialdehyde (MDA).   In an assay called the TBA assay, 
thiobarbituric acid (TBA) reacts with MDA and forms a colorimetric change that can be 
measured at an absorbance of 532nm [60].  
 Superoxide levels can be estimated through the cytochrome C reduction assay.  
Superoxide reduces ferricytochrome C to ferrocyrochrome C [109].  Addition of cell 
lysate containing superoxide to cytochrome C causes the oxidation of iron and a 
colorimetric change that is monitored kinetically through absorbance readings at 
wavelength of 550nm.  Superoxide dismutase can be added to determine the extent of 
inhibition, and increases specificity of the assay [109]. 
Dichlorodihydrofluorescein diacetate (DCFH-DA) assays measures the oxidation 
of 2’-7’dichlorodihyrofluorescin diacetate (DCFH-DA) to the fluorescent compound 2’-
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7’-dichlorofluorescein (DCF).  Cells internalize DCFH-DA and it becomes “trapped” 
intracellularly after cleavage by intracellular esterases and forms the non-fluorescent 
DCF.  Upon oxidation, DCF becomes highly fluorescent.  This fluorescence can be 
measured by flow cytometry or fluorescent microscopy [109, 112].  
1.6 Stress, Chemotaxis, And Immunity 
 An effective immune response relies on efficient, directional movement of 
immune cells, known as chemotaxis.  The elimination of an infection requires efficient 
chemotaxis of immune cells to the site of infection.  The stress of an infection changes 
the expression of cellular effector molecules, and thus the migration of cells.  Dendritic 
Cells (DCs), PMNs, macrophages and T cells can all recognize microbe-associated 
molecular patterns (MAMPs), such as fmet-leu-phe (fMLP). This formylated tripeptide is 
associated with many bacterial infections and is recognized by toll-like receptors (TLRs) 
on the surface of responding cells.  MAMPs stimulate host cells to produce chemokines 
and can cause an influx of effector immune cells to the point of infection [113].  Cells in 
the bloodstream must respond to small effector molecules called chemokines, in order to 
migrate to the location of infection [114].  Cell-adhesion molecules called intercellular 
adhesion molecules (ICAMs) expressed on the surface of endothelial cells bind with 
integrins expressed on the surface of leukocytes [115].  Integrins can be in active states, 
in which they tightly bind ICAMs, or inactive states, in which integrin-ICAM interactions 
are weak.  These states change in response to extracellular stimuli.   When integrin-
ICAM interaction is strong, leukocytes can attach to the surface of endothelial cells and 
extravasate through the endothelial barrier.  Once in tissues, chemokines direct the 
leukocytes to infected portion of the tissue.  In the mucosal immune response, cells from 
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the bloodstream must cross the endothelial barrier, as well as the epithelial barrier [115].  
Lymphocytes involved in the mucosal immune response express the integrin α4β7, which 
binds to the addressin MAdCAM-1 [115].  MAdCAM-1 is specifically expressed on 
endothelial cells of the blood vessels of the mucosa [115].  The binding of MAdCAM-1 
to integrin α4β7 signals the lymphocyte to move through the endothelium into the lamina 
propia.  Once in the lamina propia, chemokine receptors on the lymphocytes and 
chemokines produced specifically by mucosal epithelial cells home the lymphocytes to 
the mucosal epithelium [115].    
An interruption in the regulation of cell movement can cause the development of 
autoimmune disease.  For example, IL-8 over expression causes cellular movement of 
PMNs during autoimmune disease states such as psoriasis, RA, and ulcerative colitis 
[116-118].   The movement of PMNs increases the inflammatory response and 
exacerbates these inflammatory disease states.  Chemokine expression can be altered in 
the presence of stress, which in turn changes the immune response to infection and alters 
inflammatory disease states.   
 
1.6.1 Chemokine families 
 Inflammatory chemokines recruit and direct cells during inflammation, infection, 
tissue injury, wound healing, and developmental processes [113].  During an infection 
chemokines initially direct the short-lived PMNs to the site of infection first. The 
clearance of many pathogens depends on the proper migration and activation of PMNs  
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[113, 119-121].  Chemokines direct mature DCs to lymphoid tissues where they present 
antigen to T cells and initiate an adaptive immune response [122].   
 Chemokines are categorized into four chemokine subfamilies defined by the first 
cysteine motifs: CXC, CC, C, CX3C [123].  Chemokines that direct cells during 
hematopoiesis in the bone marrow are called homeostatic chemokines.  For example, the 
chemokine CCL21 works in conjunction with its cognate receptor CCR7 in the 
development of lymph nodes [124].  Formation of lymph-node structures and the 
recruitment of T and B cells are dependent on CCL21expression in the pancreas [124].  
Other chemokines that recruit effector cells during infection, inflammation, tissue injury, 
and wound healing are called inflammatory cytokines [113].  Neutrophils are rapidly 
recruited to the site of infection and can influence the recruitment of other immune cell 
types, such as dendritic cells (DCs) to the site of infection through the secretion of the 
chemokine CCL3.  A decrease in the functionality of neutrophil-derived CCL3 results in 
a decrease of the recruitment of DCs and a greater susceptibility to invading pathogens 
[125]. Some chemokines like SDF-1α are involved in both inflammatory and 
homeostatic processes through the release of neutrophils from the bone marrow upon 
infection as well as the homing of inflammatory cells in the bone marrow in the absence 
of infection [126]. 
G-protein coupled receptors (GPCRs) expressed on the surface of cells mediate 
chemokine signaling.  Once activated, GPCR stimulate phospholipase C, 
phosphoinositide-3 kinases and c-src family of tyrosine kinases [123, 127]. Different 
chemotactic responses rely on the expression of specific GPCRs.  For example, PMNs 
increase expression of CXCR4 as they mature, which direct PMNs back to the bone 
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marrow [128].   An adaptive immune response relies on the expression of CXCR3 and 
CXCR5 to guide plasma cells from the spleen to the sites of inflammation [129].   Once 
activated, a chemokine receptor becomes phosphorylated and internalized, which causes 
an interruption of responsiveness called desensitization.  The receptor can be then be 
rapidly recycled and re-expressed on the cell surface.  If the receptor is degraded upon 
internalization instead of recycled, the cell does not re-express the receptor and is 
subsequently desensitized to the signal of the chemokine and will no longer migrate 
[123]. 
 
1.6.2 MT chemotaxis 
 Chemokine genes map closely to MT genes in both humans and mice [46, 47, 
130]. MT induces chemotaxis of splenocytes and leukocytes when measured in the in 
vitro Boyden Chamber and ECIS/Taxis assays.  Jurkat T cells respond to MT in a dose 
dependent fashion, and a monoclonal antibody to MT blocks this response [130].   
Cholera and pertussis toxins block GPCR signaling and block MT mediated chemotaxis, 
which suggests MT signals through a GPCR [130]. 
 
1.6.3 In vitro Chemotactic assays  
 The Boyden chamber, or transwell chamber, is the most common in vitro 
measurement of chemotaxis.  In this assay, a porous membrane separates chemoattractant 
from cells.  As the cells responded to the chemoattractant, they crawl through the 
membrane and adhere to the underside of the membrane or drop into the well below 
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[131].  The membrane is then stained and cells are counted under a microscope.  Cells 
from the wells below can also be collected and counted.  In this assay, cells are presented 
with a steep chemoattractant gradient, which only poorly represents actual biological 
systems [132].  This assay also can only be configured as an endpoint assay since the 
chamber must be disassembled to visually count migrated cells.  
 An alternative to the Boyden Chamber, the under-agarose assay measures cell 
movement across a thin aqueous film that forms beneath a layer of agarose that covers a 
substrate [133, 134].  Two troughs are cut in the agarose and cells are placed in one 
trough opposite the chemoattractant trough.  Chemoattractant diffuses through the 
agarose and creates a shallow gradient through the agarose.  This is thought to be a better 
representation of in vivo chemoattractant gradients than the steep gradient formed in the 
Boyden Chamber [135]. Movement of cells in an under-agarose assay is commonly 
measured with microscopy.  Analysis of this assays allows for the tracking of individual 
cells through the agarose overtime.   
 The ECIS/Taxis assay combines the under-agarose approach with electric cell-
substrate impedance sensing (ECIS) technology [136, 137].  The agarose matrix 
configuration is identical to the traditional under-agarose assay, but as cells crawl beneath 
the agarose toward the chemoattractant they cross an electrode located between the cell 
and chemoattractant wells.   As cells cross the electrode they impede the current flow and 
resistance at the electrode increases [137].  Chemotaxis is monitored by changes in 
resistance at that electrode over time.  This assay allows for real-time, objective, 
measurement of cell movement.  It also allows for the calculation of cellular speed in 
response to an established gradient [135, 138-140]. 
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1.7 The Bacterial Stress Response 
 Bacterial cells also have the ability to adapt to stressful environments.  The most 
studied bacterial stress response, often referred to as the heat-shock response, involves 
HSPs, similar in structure to mammalian HSPs [141].  Induction of the heat-shock 
response is not limited to heat stress, but is also induced by exposure to ethanol, heavy 
metals, high salt concentrations and interaction with eukaryotic cells [141].   Bacterial 
cells express homologues of mammalian Hsp60 and Hsp70, which are transcribed from 
the genes GroE and DnaK [142].  GroE and DnaK are chaperone proteins in bacteria that 
are induced in the bacterial heat-shock response.  The absence of these chaperone 
systems can leave the cells susceptible to elevated temperatures, oxidant exposure, or 
osmotic stressors.  However, redundancy between the two systems can protect bacteria in 
the absence of either GroE or DnaK-like chaperone systems [143]. 
 Some bacteria also express MT proteins that are up-regulated these MTs in high 
concentrations of zinc and other heavy metals.  The relationship, if any, to the bacterial 
heat-shock response is unknown.  
 
1.8 Bacterial Metallothioneins  
The literature on bacterial MTs refers to the proteins as BmtAs SmtAs, MyMTs or 
PmtAs.  BmtA describes all bacterial MTs, while SmtA, MyMT, and PmtA define classes 
of BmtAs.  The PmtAs are similar in sequence to the first categorized BmtA, SmtA, from 
the Synechococcus species of bacteria [144-146].   More recently in the literature, 
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bacterial MTs from other species of have been categorized using letters from their host 
species.  For example, the bacterial MT that is the focus of this dissertation has been 
referred to as PmtA from P. aeruginosa [147].  In this dissertation the P. aeruginosa 
bacteria MT will be referred to as PmtA. 
 
1.8.1 SmtA class of bacterial Metallothioneins 
Bacterial MTs were first identified in Synechococcus sp. [144], Synechococcus 
PC6301 [148] and Pseudmonas putida [149].  As the bacteria were adapted to grow in 
high concentrations of the heavy metal cadmium, it was found that these bacteria 
expressed an MT to adapt in high levels of this toxic metal [44].   As a member of the 
cyanobacteria family, Synechococcus is thought to be one of the earliest producers of 
oxygen, which causes the oxidation of ZnS [150].  It is likely that Cyanobacteria 
developed MT genes to regulate zinc homeostasis and prevent the oxidation of zinc 
[147]. The most well categorized bacterial MT, SmtA, from Synechococcus can bind 
zinc, cadmium, copper and mercury [151].  There seems to be evolutionary relationships 
among BmtA families, such as SmtA-like proteins from several bacterial species, but 
evolutionary relationships between bacterial MT families are not yet defined [44]. 
Another family of bacterial MTs, MyMTs, act as a copper-binding protein in the 
pathogen Mycobacterium tuberculosis [152]. Unlike other bacterial MTs, MyMT was 
found during a drug resistance screen of M. tuberculosis [152].  M. tuberculosis growth 
depends on the presence of copper and MyMT binds up to 6 copper molecules per 
protein.   MyMT may allow M. tuberculosis to compete with the host for copper [152].  
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In contrast, high concentrations of copper can be toxic to M. tuberculosis.  Copper levels 
present in the phagosomes of macrophages are sufficient to kill M. tuberculosis, as the 
minimal inhibitory concentration of copper for this pathogen is quite low [153].   Copper 
resistance is therefore essential for the survival and full virulence of this pathogen [153].   
This is the first evidence of a pathogen’s dependence on MT expression for maximum 
virulence in an infection.   
 
1.8.2. Structure of Known Bacterial Metallothioneins 
 SmtA classified from Synechococcus contains approximately 70 amino acids, 8 to 
9 of which are cysteine residues [154].  Unlike mammalian MTs, SmtA uses histidine 
residues in addition to cysteine residues to bind metals.  A mutation of the histidine 
residues results in a decreased metal binding capacity [154].  Similar to eukaryotic MT, 
the arrangements of SmtA’s cysteine residues are indicative of the four classes of 
chemokines.  SmtA binds 4 zinc or 4 cadmium molecules, and all cysteine residues 
participate in this function [155]. 
 PmtA from P. aeruginosa binds 3 zinc or 4 cadmium molecules.  Unlike 
Synechococcus SmtA, but similar to mammalian MT, zinc bound by PmtA from P. 
aeruginosa can be displaced by cadmium.  The PmtA from P. aeruginosa is slightly less 
stable the SmtA from Synechococcus PC7942, and is more prone to oxidation and 
aggregation [147]. 
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1.8.3 Metal Function and Induction  
 Synechoccoccus species that lack the smt locus, the locus responsible for PmtA 
transcription, are viable but are approximately 4 times more sensitive to zinc and 
cadmium than their wildtype counter parts [156].  This indicates cells use PmtA to 
maintain essential metal homeostasis and to combat toxic levels of metals.  
 In Synechococcus PC7942, the zinc sensing repressor SmtB induces the 
transcription of the PmtA gene in the presence of high concentrations of zinc. In high 
concentrations of zinc, SmtB dimer bind zinc and undergoes a conformational change 
that prevents SmtB from binding the repressor region of the smt locus.  When zinc levels 
decrease, SmtB releases zinc and again binds the repressor region of the gene and halt 
transcription [156].  
 
1.9 The Opportunistic Pathogen Pseudomonas aeruginosa  
Pseudomonas aeruginosa is a Gram-negative opportunistic human pathogen that 
uses O2, and nitrate, under anaerobic conditions, as a terminal electron acceptors [157], 
and is a member of the γ-proteobacteria class of bacteria [158]. As a γ-proteobacteria, P. 
aeruginosa can catabolize an array of low molecular weight organic compounds, such as 
aromatics and halogenated compounds, which can be useful in biodegradation and soil 
remediation, and also allows the bacteria to survive in many different environmental 
niches [159]. 
In an individual with a healthy immune response, the immune system deprives P. 
aeruginosa of the ability colonize in the host.  In order for the bacteria to colonize there 
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must be a disruption of the epithelial or mucosal barriers, which is often a result of burn, 
trauma, or the insertion of a ventilator [160].  In addition, P. aeruginosa commonly 
infects Cystic Fibrosis (CF) patients through colonization of the airway epithelium and 
causes massive damage to the lung tissue.  After several acute infections, P. aeruginosa 
extensively damages the airway epithelium to a point that progenitor cells cannot 
adequately respire the damage, which allows the pathogen to establish a chronic 
infection.  CF patients often succumb to the massive infections caused by P. aeruginosa. 
P. aeruginosa expresses the bacterial MT, PmtA.  PmtA shares many structural 
characteristics with the mammalian MTs, such as a small size, high cysteine content, and 
presence of CXC cysteine motif.  Current research on PmtA focuses on its metal binding 
capacity, but lacks any information on its interactions with host immune cells.  The 
characterization of eukaryotic MT as immunomodulatory protein suggests a bacterial MT 
could also possess immunomodulatory functions.  If PmtA modifies immune cell 
movement or the redox environment during infection, similar to its eukaryotic 
counterpart, it could impact the course of an P. aeruginosa infection. 
 
1.9.1 ROS and P. aeruginosa infection 
 During a P. aeruginosa infection, phagocytic cells, such as, macrophages and 
neutrophils, are the first immune cells to encounter the pathogen once it has breached the 
epithelial barrier.  A major function of these phagocytes is to produce antimicrobial 
intermediates, such as superoxide and hydrogen peroxide, and initiate signaling that 
induces an immune response to the pathogen [161, 162].  The production of ROS in an 
oxidative burst provides antimicrobial intermediates and alters cellular signals.   
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 Mice that lack the NADPH oxidase component p47phox and are exposed to P. 
aeruginosa cannot clear the pathogen as well as their wildtype counterparts [163]. 
Without a functional NADPH oxidase the immune cell cannot produce the microbiocidal 
intermediates through an oxidative burst, and also have dysfunctional redox signaling. 
Upon infection, mice that lack p47phox express less cytokines that depend on NF-κB 
signaling, such as TNFα [163].   In individuals with an uncompromised immune response 
P. aeruginosa increases neutrophils and inflammatory cytokines at the site of P. 
aeruginosa entry, and adequately combat the bacteria primarily through phagocytosis and 
the generation of ROS.  The host cells involved in the infection show a threefold increase 
in intracellular GSH and no change in indicators of oxidative stress.  This indicates that 
healthy individuals can manage oxidative stress produced by phagocytes and adequately 
eliminate P. aeruginosa.  Immune compromised individuals experience deregulation of 
many cellular processes.  This can increase oxidative stress and disrupt the oxidant 
buffering capacity of GSH  [164]. 
 P. aeruginosa also contributes to the production of ROS through a redox-active  
compound called pyocyanin.  NADH or NADPH can transfer electrons to pyocyanin and 
form superoxide and hydrogen peroxide[165].  Exposure of host cells to pyocyanin leads 
to an increase in intracellular ROS and could alter mitochondrial and cytosolic thiol 
buffering systems and alter redox sensitive signaling [165].  
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1.9.2 Immune defenses against Pseudomonas aeruginosa  
In healthy individuals, airway epithelial cells form tight junctions to prevent 
bacterial invasion.  However, in immunocompromised individuals exposed to P. 
aeruginosa, the bacteria can attach to epithelial cells and destabilize these junctions, 
which exposes more host cells for colonization. When these cells encounter bacteria, 
signaling cascades are activated to produce anti-microbial peptides to defend against P. 
aeruginosa [166, 167].  Epithelial cells also produce chemokines that recruit neutrophils 
to the site of infection [119, 121]. Epithelial cells express Toll-like Receptors (TLRs)  
that recognize MAMPs, and in turn activate various intracellular cascades involving Ras, 
Src, ERK1/2 and MAP kinases.  Lipopolysaccharide (LPS) on the surface of P. 
aeruginosa is recognized by TLR4 [168], while other lipoproteins are recognized by 
TLR1 [169].  Expression of pili and flagella by the bacterium are recognized by TLR2 
and TLR5, respectively [170, 171].  Once these TLR recognize MAMPs, cascades are 
activated, which result in the activation of the transcription factors NF-κB and AP-1, 
which in turn up-regulate inflammatory cytokines [172-174].  In P. aeruginosa infection 
NADPH-dependent redox signaling is essential for full TLR4 activation of NF-κB.  HLL 
mice, deficient in p47phox (p47phox-/- ) are unable to activate the redox sensitive 
transcription factor, NF-κB, to the same degree as wildtype HLL mice [163].  
As one of the first immune cells recruited to the site of infection in the airway, 
neutrophils are arguably the most important cell type in combating P. aeruginosa 
infection.  In murine models, the genetic or chemical depletion of neutrophils prior to 
exposure to P. aeruginosa leads to mortality of many different mouse strains [121].  Even 
very low doses of P. aeruginosa (~8cfu/ml) lead to infection and death of mice if 
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neutrophils were not present [175].  The recruitment of neutrophils relies on the 
production of chemokines from macrophages, epithelial cells, and lymphocytes [121].  
CXC chemokines are extremely important to the recruitment of neutrophils.  A blocked 
CXCR2 receptor results in decreased neutrophil influx to the site of infection and to an 
increase in mortality[121]. 
 In a P. aeruginosa-induced pneumonia the bacteria first encounter resident 
alveolar macrophages that  release cytokines and chemokines upon contact with MAMPs 
[176, 177].  These mediators are essential to the host defense, as they recruit other 
immune cells, such as neutrophils to the site of infection.  Alveolar macrophages generate 
ROS, which serve as both a microbiocidal agent and a secondary messenger in various 
signaling cascades [178].  
Alveolar macrophages can also phagocytose P. aeruginosa mediated by the FcR, 
complement 1 and 3 receptors, and the macrophage mannose receptor [179].  Despite 
these functions, the role of alveolar macrophages in acute P. aeruginosa infections is not 
clear and is often debated.  Kooguchi et. al., has reported  that a decrease in alveolar 
macrophages results in decreased neutrophils recruitment and chemokine production, 
which results in a decreased bacterial clearance in 48 hours [180].   However, Cheung et. 
al., found that a 78%-88% depletion of alveolar macrophages did not affect the survival 
of mice or bacterial clearance [181].  Due to  these conflicting reports, the importance of 
macrophages to either ingest bacteria or produce mediators important to an inflammatory 
response, remains unclear.   
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T cells also play an immunomodulatory role during acute or chronic P. 
aeruginosa infections [182].  In mice, a higher interferon gamma (IFN-γ) level, both 
systemically and at the site of infection, lead to Th1-dominated response, and mice that 
were more resistant to P. aeruginosa than mice with a Th2-dominated response. After 
day 3 of infection, there was a significant difference in bacterial load, with those mice 
mounting a Th-1 response fairing better than those with a Th2 dominated response [183].  
A Th1-dominated response also provides antibody-independent protection to chronically 
infected mice.  BALB/c mice challenged with P. aeruginosa 14 days after initial 
infection, experienced decreased mortality rates if CD4 cells shifted toward a Th1, rather 
than a Th2 response, and produced more Interleukin-12 (IL-12).   This shift did not affect 
IgG levels in re-infected mice [184].  
 Evading or modifying the immune response is essential for the bacterium to cause 
infection; therefore P. aeruginosa possesses many virulence factors, including a type 3 
secretion system and pyocyanin, that enable it to escape immune defenses. 
 
1.9.3 PmtA in P. aeruginosa infection   
 Currently, the literature lacks any information on the role of PmtA in the 
progression of P. aeruginosa infection.  The structural similarities between PmtA and 
eukaryotic MT suggest that PmtA also possesses immunomodulatory functions.  The high 
cysteine content of PmtA, although not as high as eukaryotic MT, means the thiols of 
PmtA may also be oxidized by ROS and protect the bacteria from the harmful ROS.  
Phagocytes vital to the clearance of P. aeruginosa, neutrophils and macrophages, rely on 
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an oxidative burst to kill the pathogen.  If PmtA is oxidized by ROS, it can potentially 
neutralize the immune response to P. aeruginosa.  P. aeruginosa also produces oxidative 
metabolites that cripple the host cells and allow the bacteria to colonize the host, such as 
pyocyanin.  The expression of PmtA may allow the bacteria to produce higher amounts 
of oxidant than a pathogen that lacks PmtA without compromising itself.  
 Similar to mammalian MT, PmtA cysteine residues are reminiscent of the motifs 
indicative of chemokines.  It is therefore appropriate to suggest that PmtA may influence 
immune cell function.  This could affect the ability of immune cells to get to the site of 
infection, or influence their motility once at the site of infection.  
 The similarities in structure of MT and PmtA make it reasonable to hypothesize 
that PmtA expression by P. aeruginosa influences the course of infection.  PmtA has 
potential to influence the effectiveness of the oxidative burst of phagocytes and direct 
immune cell movement, which could affect the virulence of the pathogen.  Knowledge of 
another potential virulence factor of an increasingly antibiotic resistant human pathogen 
reveals another avenue for potential therapeutic targets.  The study of PmtA is therefore 
essential to the control of this deadly human pathogen. 
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Tissue Culture 
2.1.1 Macrophage Cells 
 The murine macrophage cell line, RAW264.7 (ATCC #TIB-71), was cultured in 
37°C at 5% CO2 in RPMI 1640 (Cellgro, Cat. #10-040 ) supplemented with 10% heat 
inactivated fetal bovine serum (FBS) (Thermo Scientific, Cat. # SH300703), 100µg/mL 
penicillin/streptomycin (MP Biomedicals Cat. #1670049, 10mM HEPES buffer (MP 
Biomedicals Cat. # 1688449), and 200mM L-Glutamine (Sigma-Aldrich Cat. #56-58-9). 
 The murine alveolar macrophage cell line, MH-S (ATCC #CRL-2019) was 
acquired from the David Knecht Laboratory.  MH-S cells were cultured in 37°C at 5% 
CO2 in RPMI 1640 (Cellgro, Cat. #10-040 ) supplemented with 10% heat inactivated 
fetal bovine serum (FBS) (Thermo Scientific, Cat. # SH300703), 100µg/mL 
penicillin/streptomycin (MP Biomedicals Cat. #1670049, 10mM HEPES buffer (MP 
Biomedicals Cat. # 1688449), and 200mM L-Glutamine (Sigma-Aldrich Cat. #56-58-9). 
 
2.1.2 T lymphocytes 
The human Jurkat T lymphocyte cell line (ATCC TIB-152), was cultured at 37°C 
with 5% CO2 in RPMI 1640 supplemented with 10% heat inactivated FBS, 25mM 
HEPES buffer, 4mM L-Glutamine, 1% penicillin/streptomycin. 
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2.1.3 Sterile Technique 
 Macrophage cells adhere to the bottom of plastic of tissue culture flasks, therefore 
Raw264.7 cells were scraped from the bottom of a tissue culture flask with a sterile cell 
scraper.  The macrophage cells were then transferred to a new tissue culture flask, at a 
desired density, in supplemented RPMI 1640 media described in 2.1.1.  
 Human Jurkat T lymphocyte cells do not adhere to the bottom of plastic tissue 
culture flasks. Spent media containing cells and cellular debris, was aspirated from the 
flasks and replaced with fresh supplemented RPMI 1640 media described in 2.1.2.  Cells 
were passed before they reached a concentration of 1x106 cell/ml. 
2.1.4 Trypan Blue Exclusion  
 The survival and percent viability of each cell type were determined through 
trypan blue exclusion.  An equal volume of cell suspension and trypan blue were 
combined in a single tube.  The trypan blue and cell suspension was added to a 
hemocytometer and viewed under a light microscope.  Blue cells were able to take up the 
trypan blue due to a compromised cell membrane and were not considered viable.    
 
2.2 Bacterial Growth 
2.2.1 E. coli MC1061 +pGex-6p-PmtA and pGEX-6p-1 in Rich media, expressing 
Plasmid proteins 
Escherichia coli was cultured in a standard YTA media comprised of 1.6% 
bactotryptone, 1% yeast extract, and 0.5% sodium chloride. Expression of the pGEX-6p-
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1 based plasmids in E. coli MC1061 required the addition of 100µg/mL ampicillin, and 
induction of the gene encoded on the plasmid required the addition of 100µM Isopropyl 
β-D-thiogalactopyranoside (IPTG).  
2.2.2 E. coli MC1061 + pDual and pDual-PmtA in Rich media, expressing Plasmid 
proteins 
E. coli expressing the pDual based plasmids were also cultured in standard YTA 
media. Expression of the pDual based plasmids in E. coli MC1061 required the addition 
of 100µg/mL kanamycin and induction of the gene encoded on the plasmid required the 
addition of 100µM IPTG. 
2.2.3 Growth of P. aeruginosa wildtype strain, PAO1  
 P. aeruginosa PAO1 was cultured in YTA media.  No antibiotic was used for this 
strain.  
2.2.4 Growth of P. aeruginosa PmtA knockout strain, PW4670  
 P. aeruginosa PW4670 was received from the Manoil lab at Washington 
University on a culture slant.  The mutant was streaked out on a YTA plate supplemented 
with 5µg/ml tetracycline (Tet5) plates.   A single colony from the mutant strain was 
cultured in 5ml YTA media with Tet5 overnight with vigorous shaking at 37°C.  The 
mutant underwent 2 more selections on Tet5 YTA plates and was grown overnight at 
37°C in YTA with Tet5 overnight with vigorous shaking at 37°C.   It was then frozen in 
the -80°C freezer in 50% glycerol.   
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PW4670 was grown for experiments in YTA media supplemented with Tet5 and 
stored on YTA plus Tet5 plates at 4°C.  
 
2.3 Generation of purified GST or GST-PmtA from E. coli MC1061 
Expressing the pGEX-6p-PmtA or the pGEX-6p-1 plasmid 
2.3.1 Growth and expression of plasmid PmtA 
YTA media containing 100µg/mL ampicillin was inoculated with a single colony 
of E. coli MC1061 expressing either the pGEX-6p-1 plasmid to purify GST or the pGEX-
6p-PmtA plasmid to purify GST-PmtA, and grown overnight at 37°C with shaking.  The 
overnight culture was diluted 1:100 the following day in 75ml of fresh YTA containing 
ampicillin. This culture was grown for 48 hours, and induced with 100µM IPTG at 3, 8, 
24, 30, 33 and 46 hours after inoculation. 
2.3.2 E. coli Lysis 
The 75mL of E. coli was centrifuged at 2,000xg for 15 minutes in 3, 25ml 
aliquots.  The 3 pellets were then combined into a single tube and suspended in 5mL of 
PBS containing 1% Triton-X-100 and incubated on a rotating platform at 4°C for 4 hours.  
At this point, the lysate could be frozen at -20°C for later use.  
2.3.3 Purification of GST-PmtA or GST 
If the lysate was frozen, it was thawed at room temperature.  The lysate was 
centrifuged and the supernatant was exposed to ProCatch Glutathione  Resin (Miltenyi 
Biotech, Auburn CA, Cat. #130-092-186), prepared according to manufacture 
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instructions, for 2 hours at 4°C.  The resin was washed 3 times with PBS before GST-
PmtA or GST was eluted from the resin with 50mM Tris-HCl pH 8.0 plus 10mM reduced 
glutathione.  The protein was dialyzed against PBS with a 12,000-14,000 molecular 
weight cut off dialysis membrane to rid the purified product of free glutathione.  The 
supernatant was then transferred to a fresh microcentrifuge tube, labeled and stored at -
20°C for analysis.  The resin was suspended again in 1mL elution buffer, and the elution 
process repeated twice.  
 
2.3.4 Confirmation of purified GST and GST-PmtA (SDS-PAGE and Western Blot) 
The presence, and purification of GST-PmtA or GST was confirmed through  
SDS-PAGE and Western blot analysis. The purified GST-PmtA was added to 6x loading 
buffer (69.7% 0.5M Tris-Cl, 30% Glycerol, 0.1% SDS, 0.093% dithiothreitol, 0.012% 
bromophenol blue) and heated for 5 min in a 95°C water bath. The 6x loading buffer was 
also added the Full Range Rainbow molecular weight marker (GE Healthcare, 
Piscataway NJ, Cat. #RPN800E). The protein samples and ladder, were loaded into a 
12% SDS-PAGE gel and run in a Bio-Rad mini-PROTEAN Tetra Cell electrophoresis 
system (BioRad, Hercules CA, Cat. #165-8002) at 200 volts until the dye front reached 
the end of the gel.   
The gel was removed from the Bio-Rad mini gel system and placed in coomassie 
blue stain (2g Coomassie, 10% acetic acid, 25% isopropanol in dH2O), for 1 hour to stain 
total protein in the sample. After one hour the gel was removed from the Coomassie stain 
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and washed with a 45% methanol 10% acetic acid solution, until the background of the 
gel is clear.  
The samples were also analyzed through Western blot analysis. The protein was 
transferred from a separate 12% SDS-PAGE gel, that was not stained with coomassie 
blue, to a PVDF membrane (Invitrogen Life Technologies Corp., Grand Island NY, Cat. 
# IB4010-02) using the Invitrogen iBlot system (Invitrogen Life Technologies Corp., 
Grand Island NY, Cat. #IB1001) and run under the manufacturer preset program number 
3.  The PVDF was then removed from the iBlot and placed in block, consisting of 5% dry 
milk 2% Bovine serum albumin (BSA) in TBST (2.42% Tris-Base, 1.168% NaCl, pH to 
7.6, 0.1% Tween) for 1 hour. The primary anti-GST (GE Healthcare, Piscataway NJ, 27-
4577) confirmed the presence of GST (24KD) or GST-PmtA (36KD). The primary 
antibody was diluted TBST 1:1500 in a volume equivalent to the block and added 
directly to the block, and incubated for 1 hour, with gentle agitation at room temperature.  
The blot was then washed TBST 3 times for 15 minutes with gentle agitation at room 
temperature.  The secondary antibody, goat anti-mouse IgG, coupled to alkaline 
phosphatase, (Southern Biotechnology, Birmingham AL Cat. # 1031-04) was used at a 
dilution of 1:1000 in TBST, and incubated with the blot for 1 hour with gentle agitation 
at room temperature. The PVDF was then developed in developing buffer (12g Tris base, 
0.95g MgCl2, 5.85g NaCl, in 1L, adjust to pH 9.5) with 1mg/mL NBT and 50mg/mL 
BCIP in DMSO.  Distilled water was added to the membrane to stop development.   
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2.4 Determination of Unknown Protein Concentrations 
2.4.1 Bicinchoninic Acid (BCA) Protein Assay 
The BCA assay (Thermo Scientific, Rockford, Il, Pierce®, Cat. # 23225) utilizes 
the biuret reaction, in which a protein in an alkaline medium reduces Cu2+ to Cu1+.  Cu1+ 
can combine with two molecules of BCA to form a colorimetric product absorbed at 
562nm.  A standard curve of BSA, ranging from 2,000µg/ml to 25µg/ml was diluted in 
the same diluent as the unknown protein, and 10µl of the standard, or unknown protein 
sample, were loaded in triplicate to a clear, flat bottom, NUNC 96-well plate. The 
working reagent was prepared by combining 1 Part reagent B with 50 parts Reagent A.  
The working reagent was added to each well at a volume of 200µl, and the plate was 
incubated at 37°C for 30 min.  The absorbance of the plate was then read, at 560nm, on 
the Molecular Devices, Spectra Max M2 96-well plate reader. The absorbance readings 
of the unknown protein samples were then interpolated from the standard curve in order 
to determine the protein concentration.  
2.4.2 Micro BCA assay 
The micro BCA assay (Thermo Scientific, Rockford, Il, Pierce®, Product # 
23235) utilizes the same principles as the BCA assay, but is modified for protein samples 
between 0.5-20µg/ml.  BSA standards were made from 200µg/mL to 0.5µg/ml in the 
same diluent as the unknown protein sample, and 150µl of the standard, or unknown 
protein samples, were loaded in triplicate to a clear, flat bottom, NUNC 96-well plate.  
The working reagent was prepared by combining reagents MA, MB, and MC at a ratio of 
25:25:1, and 150µl of the working reagent was added to each well.  The plate was then 
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covered and incubated at 37°C for 2 hours.  The absorbance was then read at 560nm, on 
the Molecular Devices, Spectra Max M2 96-well plate reader. The absorbance readings 
of the unknown protein samples were than compared to the standard curve in order to 
determine the protein concentration.  
2.4.3 Bradford assay 
 The Quick Start Bio-Rad Bradford Assay (Bio-Rad Laboratories, Hercules,CA, 
Cat# 500-0203) was used to determine the concentration of an unknown protein when a 
reagent used in the preparation of the protein was not compatible with a BCA or 
microBCA assay.  In particular, the Bradford assay was used to determine the 
concentration of GST or GST-PmtA purified from E. coli, because the L-glutathione used 
to elute the GST tagged protein from the GSH binding resin is not compatible with the 
BCA assay. A standard of gamma-globulin protein, ranging in concentration from 
2,000µg/mL to 125µg/mL, was prepared in the same diluent as the unknown proteins, 
and 20µl of the standard or samples, was combined with 1mL 2x Dye Reagent in a 
cuvette.  The cuvettes were incubated at room temperature for at least 5 min and then the 
absorbance was read at 596nm on a spectrophotometer.  A standard curve of the 
absorbance readings vs. protein concentrations of the standards was created and the 
unknown protein samples were then interpolated from the standard curve to determine the 
concentrations of the samples. 
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2.5 Bacterial Cell Assays 
2.5.1 Bacterial Growth Curves 
 2.5.1.1 E. coli expressing pGEX-6p-1 and pGEX-6p-PmtA plasmids 
E. coli expressing pGEX-6p-1 or pGEX-6p-PmtA plasmids was grown in YTA 
media with ampicillin overnight at 37°C with vigorous shaking. The overnight culture 
was transferred to fresh YTA with ampicillin at a dilution of 1:100 and incubated at 37°C 
with vigorous shaking. The growth of the bacteria was monitored through OD600nm 
readings in 96 well NUNC plates.  When the culture reached early log phase (OD600 
~0.2) IPTG was added to the culture.  The OD600 readings were used to continue to 
monitor the growth.  In addition to the OD600 readings, 100µl of the culture was removed 
to be diluted and spread on YTA +ampicillin plates.  The plates were incubated overnight 
at 37°C and counted the following day and the cfu/ml was determined for each time 
point.  Data can be shown as OD600 vs. cfu/ml. 
2.5.1.2 E. coli expressing pDual and pDual-PmtA plasmids 
E. coli expressing pDual or pDual-PmtA plasmids were grown in YTA media 
with kanamycin overnight at 37°C with vigorous shaking. The overnight culture was 
transferred to fresh YTA with kanamycin at a dilution of 1:100 and incubated at 37°C 
with vigorous shaking. The growth of the bacteria was monitored through OD600nm 
readings in 96 well NUNC plates.  When the culture reached early log phase (OD600 
~0.2) IPTG was added to the culture.  The OD600 readings were used to continue to 
monitor the growth.  In addition to the OD600 readings, 100µl of the culture was removed 
to be diluted and spread on YTA +kanamycin plates.  The plates were incubated 
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overnight at 37°C and counted the following day and the cfu/ml was determined for each 
time point.  Data can be shown as OD600 vs. cfu/ml. 
2.5.1.3 P. aeruginosa PAO1 and PW4670 
 P. aeruginosa strains PAO1 and PW4670 were grown overnight in YTA 
media or YTA media with Tet5, respectively.  The overnight culture was transferred to 
fresh YTA media without antibiotic, for both strains.  Growth was monitored for the first 
3 hours by transferring 600µl of the culture to a NUNC 96 well plate in triplicate and 
reading the absorbance at 600nm.  After the first 3 hours, P. aeruginosa forms 
aggregates, which makes it difficult to obtain accurate readings.  Therefore, the culture 
was diluted 1:10 in YTA media and the OD600nm was determined.  In addition to the 
OD600 readings, 100µl of the culture was removed to be diluted and spread on YTA 
plates.  The plates were incubated overnight at 37°C and counted the following day and 
the cfu/ml was determined for each time point.  Data can be shown as OD600 vs. cfu/ml. 
2.5.2 E.coli and P. aeruginosa growth in the presence of oxidant 
 All cells were grown overnight in the presence of the appropriate antibiotic 
indicated in 2.2.  The next morning, overnight cultures were transferred 1:100 to fresh 
YTA media with induced with IPTG.  P. aeruginosa overnight cultures were transferred 
1:100 to fresh YTA media without antibiotics.   
 Bacterial cultured diluted 1:100 were grown to early-log phase (OD600nm ~0.25 -
0.35).  Once bacterial cultures reached the proper OD600nm, oxidant diluted in dH2O was 
added directly to the cultures.  The OD600nm readings were used to monitor the growth of 
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the cultures after oxidant addition for at least 3 hours.  In some experiments, samples 
were taken and spread on YTA plates to calculate the cfu/ml of the cultures.  
2.5.3 Measurement of Pyocyanin production by P. aeruginosa strains PAO1 and 
PW4670 
 A single colony of P. aeruginosa strains PAO1 and PW4670 were grown 
overnight in 5ml of YTA media or 5ml YTA media with Tet5, respectively, at 37°C with 
vigorous shaking. Both PAO1 and PW4670 cultures were transferred to 50ml YTA 
media without antibiotics at a dilution of 1:100 at 37°C with vigorous shaking.  To 
measure pyocyanin, 1ml of the culture was removed and centrifuged form 1 minute at 
20,500xg. The supernatant was transferred to a fresh microcentrifuge tube and vortexed 
vigorously.  The supernatant was then placed in a NUNC 96 well plate in triplicate and 
the absorbance at OD691 (the maximum wavelength of pyocyanin [185]) was recorded.  
The OD600 of the bacterial culture was also monitored and data was plotted as OD600 vs. 
OD691.  Pyocyanin measurements were taken at various time points over a duration of 30 
hours.   
 2.5.3.1 Addition of L-glutathione (GSH) to PW4670 
A single colony of P. aeruginosa strains PAO1 and PW4670 were grown 
overnight in 5ml of YTA media or 5ml YTA media with Tet5, respectively, at 37°C with 
vigorous shaking. Both PAO1 and PW4670 cultures were transferred to 50ml YTA 
media without antibiotics at a dilution of 1:100 at 37°C with vigorous shaking.  A third 
flask containing PW4670  was supplemented with 10mM GSH and incubated at 37°C 
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with vigorous shaking.  Pyocyanin and growth was measured according to methods in 
2.5.3. 
2.5.2 CPM assay 
The CPM assay is a technique that uses a thiol-specific fluorochrome (N-[4-(7-
diethylamino-4-methy-3-coumarinyl)phenyl]malemide) (CPM) to quantitate cellular or 
plasma thiols [186].  This assay was used to measure free thiol in PmtA expressing 
E.coli.  A standard was created by diluting reduced glutathione (GSH) at a stock 
concentration of 10mM to 12 concentrations between 10nm to 0.045nm.  An overnight 
culture of expressing either the pGEX-6p-1 or pGEX-6p-PmtA plasmids were transferred 
to fresh YTA media (1:50) and grown to log phase (~0.2 OD600) in the presence of 
100µM IPTG and 100µg/ml ampicillin.  P. aeruginosa wildtype strain PA01 and the 
PmtA knockout strain PW4670 were also cultured 1:50 in YTA and grown to and OD600 
of 0.2-0.3.  
To determine the total free thiol content of the bacteria, the log phase bacterial 
cells were centrifuged for 4 min at 10,000rpm and washed with 1mL PBS. In order to 
determine the free thiol content of bacteria in the presence of oxidative stress, log phase 
bacteria were exposed to 10mM H2O2 for one hour at 37°C, and then centrifuged for 4 
min at 10,000rpm and washed with 1mL PBS.   This centrifugation and wash was 
repeated twice, for both configurations of the CPM assay.   The bacterial cells were 
suspended to a concentration of 1x108cell/ml and 100 µl of the GSH standards and 
bacterial cell suspensions were then plated in triplicate in an immunoflour 2 flat-bottom 
96-well black plate.  PBS was used as a blank for the system. Following the addition of 
samples, 100µl of CPM working solution (1mM EDTA 0.5% Nonidet P-40, 0.01mg/ml 
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CPM, in PBS) was added, and the plate was incubated at room temperature in the dark 
for 1 hour.  After incubation the end point fluorescence of each well was measured on a 
Molecular Devices Spectramax M2 96-well plate reader at an excitation wavelength 
387nm and an emission wavelength of 465nm.  The GSH standards were graphed on 
Softmax Pro software, and the nm of free thiol present in the each bacterial sample was 
calculated by interpolation of the standard curve.  
2.5.3 Pyocyanin Extraction  
 P. aeruginosa strains PAO1 and PW4670 were grown for 30 hours and at least 
10mL of cell free supernatant was obtained as described in 2.5.3.  In the fume hood, 
4.5ml of chloroform was added to 7.5ml of supernatant from each strain.  The mixture 
was then vigorously vortexed for 2 minutes until the chloroform turned blue-green in 
color.  The tubes were centrifuged for 10 minutes at 4°C and 3000xg.  At this point, the 
bottom layer appeared blue and 3ml of this was transferred to a new tube.  The 
absorbance of the blue pyocyanin was measured at 300nm.  HCl (1.5ml of 0.2M) was 
transferred to the blue pyocyanin and vortexed vigorously for 2 minutes.  The top blue 
layer turned pink and samples were centrifuged for 2 min at 4°C and 3000xg.  The 
absorbance of pyocyanin at the pink stage was measured at 520nm.  
2.5.4 Biofilm Formation Assay 
The biofilm microtiter plate assay was performed as previously described in 
O’Toole et. al, 2011 with minor adaptations [187].  In brief, fresh YTA media was 
inoculated at a 1:10 dilution with a stationary phase overnight culture.  Cells were grown 
for 24 hours in 37°C without any shaking.  Growth yields were measured with an 
absorbance reading at 595nm.  Media was removed and biofilms were fixed to the side of 
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the microtiter plate with 90% methanol.  Biofilms were stained with 0.1% Crystal violet 
for 40 minutes and washed with dH2O.  An ethanol:acetone (4:1) suspension was added 
to each well and incubated for 10 minutes.  The liquid was then removed from each well, 
transferred to a new 96 well microtiter plate, and the amount of crystal violet in each well 
was determined with an absorbance reading at 595nm.  The relative biofilm formation 
(rbf) for each well was determined by dividing the crystal violet absorbance reading by 
the growth yield absorbance reading.  Any ratios above 1.0 were disregarded in statistical 
analysis.  
 
2.6 In Vitro Chemotaxis Assays  
2.6.1 Pre-incubation of Jurkat T cells with GST or GST-PmtA 
Jurkat T cells were exposed to 15µM or 5.6 µM of GST or 15µM or 5.6µM GST-
PmtA in complete RPMI media for 50 minutes at 37°C in a 5% CO2, humidity controlled 
incubator.  The cells were then washed with 1ml complete RPMI.  Cells that were 
analyzed for cell motility were then suspended to a concentration of 2x106 cell/ml.  Cells 
that were to undergo cell surface staining were suspended in 1ml FACS buffer (0.09% 
sodium azide, 0.5% FBS in PBS) and incubated on ice. The cells were then washed and 
suspended to 1x105cell/condition in FACS buffer.  
2.6.2 Boyden Chamber 
For the studies analyzing GST-PmtA’s ability to induce Jurkat T cell chemotaxis, 
SDF1-α (25nM), GST-PmtA (14uM), GST (14uM) or RPMI was added to the bottom 
chamber (30µl), while Jurkat T cells (2x106cell/ml) were added to the top chamber 
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(50µl).  In the studies that analyzed PmtA’s ability to block Jurkat T cell chemotaxis to 
its natural ligand, SDF-1α, Jurkat T cells (2x106cell/mL) pre-incubated with GST (14uM) 
or GST-PmtA (14uM) and were then.  Cells were incubated in the Boyden chamber for 4 
hours with 5% CO2 at 37°C.  After 4 hours the chamber was disassembled and the side of 
the polycarbonate membrane that was in contact with the bottom chamber was stained 
with the Hema-3 Stat pack and cells were counted with a light microscope.   
2.6.3 ECIS/Taxis 
These assays were performed as described previously, with minor adaptations 
[140].  The cysteine treated gold ECIS/Taxis electrodes, supplied by Applied Biophysics, 
Inc. (Troy, NY) were filled with 0.5% agarose made in complete RPMI media. Two wells 
were cut n the agarose on either side of the target electrode with 14 gauge cannulae 
approximately 2mm apart.  For the studies analyzing GST-PmtA’s ability to induce 
Jurkat T cell chemotaxis, Jurkat T cells (2x106cell/ml) were added to one well, while the 
other contained SDF1-α, PmtA, GST, or RMPI control.  In the studies that analyzed 
PmtA’s ability to block Jurkat T cell chemotaxis to its natural ligand, SDF-1α, Jurkat T 
cells (2x106cell/mL) pre-incubated with GST or GST-PmtA were exposed to SDF-1α 
(25nM) in the opposing well.  The electrodes were connected to the ECIS array holder in 
a 37°C, humidity controlled, 5% CO2 incubator.  The ECISθ software was used to record 
the increase in resistance over approximately 35 hours at 4,000hertz.   
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Figure 2.1 ECIS/Taxis System. A.) A Side view of a single chamber in which 
wells have been cut in the agarose surrounding the target electrode. B.) Top view of an 
ECIS/Taxis electrode without agarose. Each ECIS/Taxis electrode is comprised of 8 
individual chambers.  Each chamber shares a large electrode (a), and individual target 
electrodes (b).  Each chamber also has 2 gold circles that serve as aiming points (c), 
where one well cut in overlaid agarose will contain chemoattractant and the other will 
contain cell suspension. The gold squares (e) are the contact pads that connect to the pogo 
pins on the array holder to AC current. The individual target electrodes are each in circuit 
with larger counter electrode (d).  
 
2.7 In vitro Cell Assays 
2.7.1 Measurement of Surface Protein Expression 
PmtA’s ability influence CXCR4 or CD3 surface expression was assessed using 
flow cytometry and fluorescent microscopy.  Some Jurkat T cell cells incubated with 
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GST or GST-PmtA and suspended to 1x105cell/condition and were subsequently exposed 
to SDF-1α at 0.75nM for 1 hour at 37°C in a 5% CO2, humidity controlled incubator.  
SDF-1α induced CXCR4 internalization was measured in this population of cells.  Other 
Jurkat T cells were not exposed to SDF-1α after GST and GST-PmtA incubation and 
were stained for CXCR4 and CD3 expression. 
The measurement of CXCR4 expression required incubation with 100µl of anti-
CXCR4 IgG(R&D Systems, Minneapolis MN, Cat. #MAB172) at a dilution of 1:2000 
for 25 minutes at room temperature.  The measurement of CD3 expression required 
incubation with 100µl of anti-CD3 (Thermo Scientific, Cat. #MA5-14524) at a dilution 
of 1:2000 for 25minutes at room temperature.  The cells were washed with 1ml FACS 
buffer, and suspended in 100µl of fluorescein isothicyanate (FITC)-labeled goat anti-
mouse IgG (Southern Biotechnology, Birmingham AL, Cat. #030-02), at a concentration 
of 1µg/ml for 20 minutes at 25°C. For flow cytometry, the cells were suspended in 0.2ml 
FACS Buffer in 12x75mm tubes and fixed with 4% paraformaldehyde.  The presence of 
FITC on the cell surface was analyzed via the FACS Calibur, and analyzed suing FlowJo 
Software. For fluorescent microcopy, the cells were suspended in 10µl FACS buffer and 
gently spread on a glass slide with 10µl of ProLong Gold Antifade Reagent (Invitrogen 
Life Technologies, Grand Island, NY P36934).  The slide was sealed, and allowed to dry 
in the dark at 25°C.  Cells were viewed with the Zeiss Axiovert 200M inverted 
microscope equipped with a Plan 100x, 1.30 NA objective.  Images were acquired with 
the Hamamatsu Orca camera controlled by automation routines developed with Openlab 
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Software (Improvision, Inc.).   Quantification of fluorescence was measured with ImageJ 
Fiji software.  
2.7.2 Measurement of ERK Phosphorylation 
 Cells pre-incubated with GST or GST-PmtA (5.6µM) were exposed to 25nM 
SDF-1α for 15 min at 37°C and 5% CO2. The cells were then immediately fixed with 4% 
paraformaldehyde for 20 minutes at room temperature and subsequently permeablilized 
with ice-cold methanol for 20 minutes  at 4°C.  Cells were then incubated with an anti-
phospho-p44/p42 MAPK (Erk 1/2) (Thr202/Tyr203) antibody (Cell Signaling, Cat. 
#9106S) for 20 min, washed and incubated with a secondary goat anti-mouse FITC 
antibody (Southern Biotechnology Associates, Cat. #1675-OS2).  Intracellular ERK 
phosphorylation was measured via flow cytometry on the FACS Calibur, and analyzed 
with FlowJo Software.  
 
2.8 Polymerase Chair Reaction for confirmation of PmtA Mutant 
 PW4670 was acquired from the Manoil Laboratory at the University of 
Washington.  PW4670 was grown from a slant in YTA broth without antibiotic.  This 
culture was then streaked on a YTA plate with 5µg/ml tetracycline for single colony 
isolation.  A single colony on the plate was grown in YTA broth with 5µg/ml tetracycline 
overnight at 37°C with vigorous shaking.  It was then again streaked on a YTA plate with 
5µg/ml tetracycline for single colony isolation.  This was repeated 3 times.   
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 The insertion of the transposon was confirmed from single colonies on  YTA 
plates with 5µg/ml tetracycline.  A single colony was removed from the plate, boiled in 
50µl dH2O for 10 min. The PmtA Forward, PmtA Reverse, and transposon specific 
primer sequences were obtained from the Manoil Laboratory.   
Primer Name Sequence (5’-3’) Position 
PmtA Forward 
(54742R.f) 
GGTGTCGGTACCGGTGTTC 2355431 
PmtA reverse 
(54742R.r) 
GCAGTACAGGATTCCGCAGT 2356262 
Hah-138 CGGGTGCAGTAATATCGCCCT ~2356025+108 
 
The transposon was positioned in the PmtA gene in the reverse direction, therefore the 
PmtA reverse primer and the Hah-138 primers were used to confirm the insertion of the 
transposon.  
A gradient PCR reaction was used to determine the most efficient annealing 
temperature, which was determined to be 62.5°C.  For each cycle the DNA was 
denatured for 30 seconds at 95°C, the primers annealed for 30 seconds at 62.5°C, and the 
extension period was 90 seconds at 72°C.  This was repeated for 30 consecutive cycles. 
The PCR reaction was then optimized at this temperature with 15µl reactions and 
2xGoTaq Mastermix.  The components for each reaction were as follows: 
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Component Volume (µl) 
2x GoTaq 7.5 
F. Primer (or hah) 0.75 
R. Primer 0.75 
DNA 0.15 
Nuclease free water 5.85 
Total 15 
 
PCR reactions with the wildtype PAO1 DNA as a negative control were conducted in the 
same manner.  
 
2.9 Virulence studies with Galleria mellonella  
2.9.1 Virulence of Supernatant  
Live G. mellonella larvae were purchased (snackworms.com 1000 count), and 
stored at 4°C before use.  Cell-free supernatant from PAO1 and PW4670 was obtained 
after 30 hours of growth, as described in 2.5.3.  Worms were separated into 3 separate 
groups of 9 worms.  One group served as a control and was injected with 5µl of sterile 
YTA media, and the other two groups were injected with 5µl of either PAO1 supernatant 
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or PW4670 supernatant.  The worms were then incubated at 25°C for 24 hours and 
survival was assessed at this time.  
 Worms were injected with YTA or supernatant on ice with a 10µl Hamilton 
Syringe with 1/4 inch beveled tip needle.  Worms were determined healthy enough for 
injection if they were pale yellow in color and had not yet begun to melonize.  
Melonization was apparent if the worm was dark yellow, gray, or black in color (Figure 
2.2C).   Each worm was injected in its left hind pseudopod.  If a worm leaked lymph 
(yellow discharge) upon injection, it was discarded and replaced with another healthy 
worm.  Survival was assessed on by the color of the worm and the movement of worm 
after stimulation (Figure 2.2D) 
   53
 
Figure 2.2 
 
A. B.
C. D.
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Figure 2.2: Galleria mellonella model of virulence.  A.) G. mellonella 
experimental groups were placed in petri dishes during injection and incubation at 25°C.  
Only larvae yellow in color were selected for injection (B, left), while worms that showed 
any melonization were excluded from the experiments (B, right).  B.) Each G. mellonella 
larvae were injected below the left hind pseudopod as indicated by the arrow.   Larvae 
that were turned black, as seen in D.), and did not respond to stimuli were determined to 
be dead.   
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CHAPTER 3: PMTA INFLUENCES JURKAT T CELL 
CHEMOTAXIS 
 
3.1 Introduction  
 Eukaryotic MT’s influence on immune cell function has been extensively 
studied.  However, it is not known if MTs from other species also modulate mammalian 
immune cell function.   In an infection, bacterial MTs contact mammalian immune cells.  
The similarities between bacterial MTs and eukaryotic MTs suggest bacterial MTs could 
also modulate the activity of immune cells.  Modulation of immune activity by bacterial 
MTs may influence the progression of infection and the degree of virulence of an MT-
expressing bacteria.     
 The Gram negative opportunistic pathogen Pseudomonas aeruginosa expresses 
a bacterial MT known as PmtA.  Similar to eukaryotic MT, PmtA binds zinc molecules 
and contains cysteine motifs indicative of the 4 classes of chemokines [43, 44, 188].   If 
PmtA influences the activity of immune cells similar to its eukaryotic counterpart, PmtA 
might modulate the progression of P. aeruginosa infection.  As an increasing number of 
antibiotic-resistant strains of P. aeruginosa emerge, the development of new therapeutic 
regimens to treat the pathogen has become essential.  Disruption of any 
immunomodulatory function of PmtA may present a novel therapeutic approach in the 
treatment of P. aeruginosa infection.   
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 One of eukaryotic MT’s many immunomodulatory functions is its ability to 
induce chemotaxis of lymphocytes. This may operate via one or more G-Protein coupled 
receptors (GPCR) [130].  The immune response to P. aeruginosa relies on the migration 
of various immune cells, including neutrophils and T cells, to the site of infection.  Much 
of this directed migration relies on the signaling of stromal cell-derived 1α (SDF-1α) and 
is cognate GPCR CXCR4.  
3.1.1 G-Protein Coupled Receptors  
 G-protein coupled receptors (GPCR) are 7 transmembrane proteins that transduce 
signals necessary for chemotactic movement of cells.  The over 800 human GPCR are 
divided into 5 families based on the sequence similarity of the transmembrane regions of 
the protein [189].  The largest of the GPCR families is the rhodopsin family that 
encompasses 701 human GPCR, while they other four families; adhesion, frizzled/taste, 
glutamate, and secretin, encompass far fewer receptors [189].   
 Ligands that associate with GPCR are very structurally diverse.  The ligands can 
be photons, ions, small organic molecules, peptides or proteins.  The small organic 
molecules activate the receptors be binding within the transmembrane segments of the 
receptor, while  peptides and proteins bind the extracellular amino terminus of the 
receptor [190-192].  Although GPCR bind diverse ligands, the cytoplasmic domains of 
the receptors are structurally similar.  They cytoplasmic domains of GPCR activate the 
trimeric G-proteins α, β, and γ.  When the ligand binds the GPCR, the α G-protein 
subunit hydrolyzes GDP to GTP.  The hydrolysis of GDP to GTP activates the α, β, and γ 
subunits and allows them to move through the plasma membrane and activate proteins in 
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membrane.  The activation of membrane proteins by the G-protein subunits leads to an 
increase in the second messenger cyclic AMP (cAMP), which activates many signaling 
pathways and can affect transcription as well as migration [193].  If the original ligand 
continues to be bound by the GPCR, then it will continue to hydrolyze GDP to GTP and 
remain active.  They hydrolysis of GTP to GDP renders the GPCR signaling processes 
inactive.  However, with prolonged stimulation, the GPCR will be phosphorylated by a 
GPCR kinase (GRK) and become desensitized.  Phosphorylation by a GRK allows for 
arrestin to bind and the GPCR is endocytosed.  After internalization, the GPCR can either 
be broken down in lysosomes or recycled to the plasma membrane [193]. 
3.1.2 Inhibition of GPCR signaling  
 Small molecules and toxins can interfere with GPCR receptor signaling 
agonistically or antagonistically.  Cholera toxin from the bacterium Vibrio cholera is a 
hexameric protein that interferes with GPCRs.  An α subunit of the toxin can breach the 
eukaryotic cell membrane and cause ADP ribosylation of GTP, which causes constitutive 
activation of the G-protein subunits and exponentially raises cAMP levels [193].  This 
deregulated signaling inhibits the chemotaxis of cells exposed to cholera toxin [194].  
Another bacterial toxin, pertussis toxin from the bacterium Bordatella pertussis also 
blocks chemotaxis of exposed cells.  Pertussis toxin can also penetrate the eukaryotic cell 
membrane and blocks the release of GDP from G-proteins, which forces the GPCR to 
remain in an inactivate state [195-197]. 
 Pharmaceutical companies have recently focused on development of chemically 
synthesized analogs of GPCR ligands.  It is estimated that drugs that use GPCR as targets 
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account for close to 50% of proposed drugs.  Since GPCRs are active in essentially every 
organ the development of one drug that targets a GPCR can potentially be used to treat 
several disorders [198].  A complete understanding of how these receptors interact with 
small molecules, peptides, and proteins can assist in the development of these GPCR-
targeted pharmaceuticals.   
 
3.1.3 SDF-1α and its cognate receptor CXCR4 
The chemokine SDF-1, also known as CXCL12, can be assembled in either of 
two forms, SDF-1α and SDF-1β, through alternate splicing of the same gene [199, 200]. 
Both forms are chemotactic, and most in vitro research refers to SDF-1α.  In vivo, many 
cell types produce SDF-1 including stromal, endothelial, dendritic, epithelial, and 
macrophage cells [201-203]. SDF-1 signals selectively through the CXCR4 GPCR [204].   
SDF-1α signaling through CXCR4 has been studied in the context of organ development, 
hematopoiesis, HIV infection, and immune cell movement.    Developmental processes 
such B cell lymphopoesis, bone marrow colonization, organogenesis, vascularization and 
cardiac septum formation all require SDF-1 induced CXCR4 signaling [202, 205, 206]. 
After development, many tissues constitutively express SDF-1α and CXCR4 including 
the brain, heart, kidney, liver, lung and spleen [207].  The immune system relies on this 
signaling during infection and inflammatory disease states, which is evident through the 
expression of CXCR4 on lymphocytes and monocytes [208, Sanchez-Martin, 2011 
#1206].  
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SDF-1α binds and activates CXCR4 through a two-step process.  The receptor 
first interacts with amino acids 12 to 17 of SDF-1α, which causes a conformational 
change in the receptor.  The conformational change allows the first 8 amino acids of the 
chemokine to  interact with the CXCR4 binding pocket [126]. SDF-1 interaction with the 
CXCR4 binding pocket causes intracellular phosphorylation of the receptor by G protein 
coupled receptor kinase (GRK) on the first intracellular loop [209].  As the receptor 
desensitizes to the SDF-1α signal it becomes internalized [210].  Upon internalization the 
receptor can either be recycled back to the plasma membrane or degraded in lysosomes 
[211]. 
The transcription factors nuclear respirator factor-1 (NRF-1) and specificity 
protein 1 (SP-1) regulate CXCR4 transcription[212] and SP-1 [213].  Many factors 
contribute to an increase in transcription of CXCR4 including calcium [214, 215] cyclic 
AMP [216] and cytokines including IL-2 [217] IL-4 [218] and TGF-1β [219].  
Inflammatory cytokines such as TNF-α [216] and interferon-γ and IL-1β decrease the 
expression of the receptor.  
Much of the information known about CXCR4 and SDF-1α signals involves cell 
development and hematopoiesis.  Mice deficient in CXCR4 exhibit serious defects in 
hematopoietic differentiation and die very soon after birth.  CXCR4 deficiency in mice 
causes a severe reduction in B cell lymphopoiesis and myelopoiesis in fetal liver, and an 
absence of myelopoiesis in the bone marrow when compared to wild type mice[204].   In 
contrast, CXCR4 deficiency does not affect T cell lymphopoiesis [204].    
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Recently, research into CXCR4 and SDF-1α signaling has elucidated roles 
beyond development and hematopoiesis.  CXCR4 plays roles in immune cell recruitment 
to the sites of infection, cancer, and HIV infection. 
 
 Figure 3.1: CXCR4 and SDF1α Signaling. SDF1α binds to CXCR4, a G-protein 
coupled receptor.  This leads to signaling through various pathways, which leads to an 
influx in calcium to the cell, migration, transcriptional changes, the phosphorylation of 
ERK and internalization of CXCR4.   
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3.1.4 CXCR4 function on Neutrophils 
Stromal cells in the bone marrow produce SDF-1α, which causes the retention of CXCR4 
expressing neutrophils in the bone marrow.  Reduction of SDF-1α-induced signal 
through CXCR4 causes neutrophils to traffic from the bone marrow to sites of infection 
[220, 221].  Neutrophils are often the first cell type to the site of infection, but are short 
lived.  CXCR4 expression increases on mature neutrophils and directs these cells either 
become apoptotic or traffic back to the bone marrow [128].  There is evidence that 
mature neutrophils traffic back to the bone marrow in a CXCR-4 dependent manner, but 
there is not yet evidence for the clearance of neutrophils in the bone marrow [222]. 
Disruption of the CXCR4-regulated neutrophil movement causes neutrophils to migrate 
uncontrollably and as a consequence fail to arrive at the proper sites[223].   
 
3.1.5 CXCR4 function on B and T lymphocyte 
CXCR4 and CCR5 each function as a co-receptor for HIV-1 entry in to CD4+ T 
cells.  More recently, it was discovered that SDF-1α modifies T cell movement [224].  
Mechanisms of T cell movement, as well as the physiological conditions 
necessary for T cells to migrate in response to SDF-lα, remain unclear.  It is known that 
SDF-1α induced CXCR4-mediated chemotaxis in T cells, is enhanced by the presence of 
CD45 on the surface of T cells [225].  Additionally, SDF-1α induced migration of Jurkat 
T cells that lack ZAP-70 tyrosine kinase and the adaptor protein Slp-76 decreases when 
compared to wildtype Jurkat T cells [224].  Downstream from ZAP-70 lies the Tec 
Family kinase, ITK,  [226]. ITK activates rapidly in the presence of SDF-1α, which also 
   62
activates Src Kinase and phosphatidylinositol activity (PI3K) [227].  ITK knockout T 
cells are less able to adhere, polymerize actin and migrate than wildtype a cell, which 
suggests ITK contributes to T cell migration in response to SDF-1α [227].  
SDF-1α induced signaling is vital to pre-B cell proliferation. B cells of OVA 
immunized mice expressing OVA specific antibodies are responsive to SDF-1α for 
several days after they migrated from the spleen. This suggests CXCR4-SDF-1α signals 
regulate the migration of B cells from to the bone marrow and inflamed tissues [129].  
 
3.1.6 Macrophages and CXCR4  
 Circulating monocytes experience autocrine and paracrine regulation through 
CXCR4 since these cells both secrete SDF-1 and express CXCR4[207].  These signals 
assist in the differentiation of monocytes into macrophages that express CD4, CD14 and 
CD163, as well as the differentiation of dendritic cells.  However, dendritic cells that 
undergo CXCR4 assisted differentiation have a low ability to stimulate an antigen 
specific T lymphocytes response [207].  Microarray analysis suggests that SDF-1α 
causes the increase of vascular endothelial growth factor (VEGF) mRNA and the 
chemokine CCL1 mRNA in primary monocytes.  Both of which are pro-angiogenic.   
SDF-1α also decreases expression of RUNX, a transcription factor responsible for CD4 
and CD14 expression on macrophages.  This decrease of CD4 and CD14 suppresses the 
phagocytic capacity of macrophages. Therefore, in macrophages SDF-1α is both 
immunosuppressive and pro-angiogenic [207].  
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3.1.7 The Role of CXCR4 in HIV 
 Functions of CXCR4 and CCR5 have both been studied as HIV-1 co-receptors for 
the entry of HIV-1 into CD4+ T cells.   HIV-1 cannot enter CD4+ T cells without the 
expression of CCR5.  CCR5 expression is vital to viral replication in the earlier stages of 
HIV-1 infection, CXCR4 has been reported to be essential to viral replication in later 
stages of infection [228]. Since the virus does not  affect macrophages as profoundly as 
CD4+ T cells,  macrophages do act as viral reservoirs for HIV-1 and  selectively uses 
CXCR4 to enter macrophages [229].  This process can be inhibited by the addition of 
SDF-1α[229].   
 
3.1.8 CXCR4 Signaling in the Tumor Microenvironment 
Tumor metastasis relies on the movement of tumor cells and stromal cells in the 
tumor microenvironment. CXCR4 plays a role in both single and multi cell directed 
migration in the metastasis of 11 different types of cancers and is known to be very 
abundant on the surface of many cancer cells [230, 231].  Cancer cells utilize CXCR4 
mediated signaling for angiogenesis, invasion, chemotaxis, extravasation, and homing of 
cells to the tumor microenvironment [231].  Tumor-associate macrophages express high 
levels of SDF-1 and can recruit bone marrow derived endothelial cells that express 
CXCR4 to the tumor site [232].  These cells then differentiate into tumor associated 
vascular endothelial cells [230].  
The widespread reliance of cells on CXCR4 for metastasis is exhibited in several 
different mouse model.   Transfection of B16 melanoma cell line with CXCR4 and 
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subsequent intravenous injection (i.v) into C57BL6 mice causes the formation of 
pulmonary tumors.  Mice infected with CXCR4 expressing B16 mouse melanoma cells 
accumulated 10 times the number of B16 cells in the lung, compared to CXCR- B16 cells 
[233].  This phenotype could be completely blocked with the addition of the CXCR4 
antagonist, T22 [233].  Similarly, treatment with a CXCR4 antagonist has been shown to 
reduce metastasis and primary tumor growth in mouse models of breast cancer  [234].  
CXCR4 expression also increases SDF-1α-induced  adhesion to a fibronectin substrate in 
the highly invasive BLM melanoma cell line, which increases migration and invasion of 
these cells [235].  
 
3.1.9 CXCR4 in Lung injury  
P. aeruginosa often colonizes the lungs of cystic fibrosis (CF) patients and 
patients on ventilators.  In homeostatic conditions resident progenitor epithelial cells 
constantly replace epithelial cells of the lung.  The colonization of P. aeruginosa causes 
significant injury to the airway epithelial cells and the resident progenitor epithelial cells 
are no longer able keep pace with the need for replacement of damaged cells. Circulating 
progenitor epithelial cells must be recruited to the site of injury to combat the infection.  
This recruitment of epithelial cells relies heavily on CXCR4 interaction with SDF-1α.  
Interference with this process can slow or abrogate healing.  The addition of anti-SDF-1α 
antibodies blocks SDF-1α mediated signaling through the CXCR4 receptor, and prevents 
circulating progenitor epithelial cells from reaching the site of injury. [236].  
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3.1.10 Hypothesis: PmtA will modify Jurkat T cell Chemotaxis 
Eukaryotic MT induces chemotaxis of leukocytes through GPCR signaling [130].  
The MT produced by P. aeruginosa, PmtA, shares structural similarities with the 
eukaryotic MT and chemokines.  The structural similarities between mammalian MT and 
PmtA provide the basis for the hypothesis that PmtA can affect the chemotaxis of 
immune cells.  Mammalian MT and PmtA are both small proteins.  Mammalian MT’s are 
60 to 68 amino acids in length, while PmtA from Pseudomonas species vary in 56 to 79 
amino acids in length [1, 43, 44].  The P. aeruginosa PmtA, from strain PAO1 contains 
79 amino acids.  Despite the longer sequence of PmtA, it has only half the number of 
cysteine residues of mammalian MT, and binds approximately half the amount of zinc 
[188] (Table 3-1).  Unlike mammalian MT, PmtA contains histidine residues. In the 
Synechococcus elongatus PCC7942 SmtA these histidine residues are vital to the metal 
binding capacity of the protein.  Site-directed mutagenesis of the histidine residues 
decreases the number of zinc molecules bound by PmtA [237].  
 An analysis of the primary amino acid sequence of PmtA and MT reveals that 
both contain CXC motifs at the N-termini (Figure 3-1).   In chemokines, the N-terminus 
cysteine motif categorizes the chemokines into the C, CC, CXC, or CX3C chemokine 
families.  This similarity between MT and PmtA could suggest that PmtA may also have 
a chemotactic function.  Despite the similarities in metal binding capacity, cysteine 
content, and cysteine motifs, a BLAST comparison between P. aeruginosa PAO1 and 
mammalian MT-1 from humans does not suggest sequence homology (e=6).  
The observation that P. aeruginosa PmtA displays similarities with both MT and 
chemokines leads to the hypothesis that PmtA influences cellular chemotaxis.  If PmtA 
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affects immune cell chemotaxis it could disrupt the host response to the infection, and 
thus act as a virulence factor for the bacterium.  If PmtA acts as a chemoattractant, it 
could disrupt the signals necessary for immune cells traffic to the site of infection.  PmtA 
may also block chemotaxis of immune cells toward chemoattractants by acting directly or 
indirectly on the receptor.   
Jurkat T cells were chosen to address PmtA’s effects on CXCR4 mediated 
migration because of eukaryotic MT’s previously established ability to stimulate 
chemotaxis of Jurkat T cells, and since these cells display a robust chemotactic response 
to SDF-1α in vitro [130, 224]. Jurkat T cells also lack toll-like receptor 4 (TLR-4), which 
responds to LPS from bacterial cells [238].   Thus the Jurkat T cell model should not be 
sensitive to any contaminating endotoxin co-purifying with GST-PmtA. Lung infections, 
like those caused by P. aeruginosa, rely on CXCR4 signaling on many cell types to 
combat the infection and repair damage to epithelial cells.  Therefore, the Jurkat T cell 
model is an appropriate model to determine of PmtA influences CXCR4-mediated 
immune cell chemotaxis.  
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 PmtA 
(Pseudomonas 
species) 
SmtA 
(Synechococcus 
Species 
Mammalian MT 
# of Amino 
Acids 
56-79 55-56 60-68 
# of Cysteine 
Residues 
8-10 8-10 18-23 
# of Bound 
Zinc 
3-4 3-4 7-8 
 
Table 3.1: Comparison of PmtA from Pseudomonas species and Mammalian 
Metallothionein.   Mammalian MT contains nearly twice as many cysteine residues as 
PmtA’s, which allows it to bind twice as many bound zinc molecules [188].  
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Figure 3.1: Alignment of P. aeruginosa PmtA and Homo Sapien Metallothionein I.  
The MT from P. aeruginosa PAO1 contains 79 amino acids, in 10 of which  are cysteine 
residues.   This makes it the largest MT from Pseudomonas species with the highest 
number of cysteine residues.  Unlike mammalian MT,  PAO1 MT contains histidine (H) 
residues that are necessary for metal binding.  Similarly, the first cysteine motif, the motif 
used to classify chemokines, of both MT’s is a CXC motif.  A BLAST comparison of 
both human MTI and PAO1 PmtA reveals there is little homology between the sequences 
(e=6), but the alignment reveals many of the fully conserved regions (*) are cysteine 
residues.  A (:) indicates conservation of amino acids with strongly similar properties, 
while (.) indicates conservation of amino acids with weakly similar properties [239-242].  
The yellow boxes indicate the conserved cysteine residues in both MT-1 and PmtA. 
  
  MD------PNCSCTTGVSCA-------CTGSCKCKECKCTSCKKSCCSCCPVGCAKCAHG 47
  MNSETCACPKCTCQPGADAVERDGQHYCCAACASGHPQGEPCRDADCPCGGTTRPQVAED 60
  *:      *:*:* .*....       * .:* . . :  .*:.: *.*  .  .: *..
  CVCKGTLENCSCCA----- 61
  RQLDDALKETFPASDPISP 79
     ..:*::   .:     
MT
PmtA 
MT
PmtA 
Alignment of Homo sapien MT-1 and P. aeruginosa PAO1 PmtA
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3.2 Results 
3.2.1 Structural Prediction of P. aeruginosa PmtA 
The structure of P. aeruginosa PmtA has yet to be defined by x-ray 
crystallography.   However, the NMR structure of S. elongates PC7942 SmtA has been 
identified, and the structure is available on the NCBI MMDB database [237].   With this 
information, the structure of P. aeruginosa PmtA could be threaded through the S. 
elongates SmtA structure using the I-tasser Protein prediction software.  The amino acid 
sequence of S. elongates SmtA is smaller than the P. aeruginosa PmtA, at 56 amino 
acids, but still contains 8 cysteine residues in that short sequence (Figure 3-2 A).   
When the 79 amino acid P. aeruginosa structure is threaded through the S. 
elongates SmtA (Figure 3-2, B), it is evident that the P. aeruginosa PmtA contains a 
much longer “tail” at the C terminus of the protein (Figure 3-2, C).   This is expected 
based on the primary amino acid sequences of the two proteins.  An interesting aspect to 
this prediction is that the P. aeruginosa PmtA seems to form a helical region S. elongates 
PmtA lacks (Figure 3-2, D). 
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Figure 3.2 
A.
B. C. 
D.
 ---mnsetcacpkctcqpg-adaverdgqhyccaacasghpqge-pcrdadcpcggttrp
 mtsttlvkcacepclcnvdpskaidrnglyycseacadghtggskgcghtgcnchg----
     .  .***  * *:   :.*::*:* :**. ***.**  *.  * .: * * *    
 qvaedrqlddalketfpasdpisp
 ------------------------
                         
PAO1 
PCC7942 
PAO1 
PCC7942 
Alignment of  P. aeruginosa PAO1 PmtA and S. elongatous 
PCC7942 SmtA 
PAO1 PmtA C-terminal Tail
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Figure 3.2: The Prediction of the P. aeruginosa PmtA structure from the S. 
elongatus SmtA Structure. An alignment of P. aeruginosa PmtA and S. elongatus SmtA 
reveals the two sequences contain very similar sequences, including conservation of the 
cysteine residues  (A).  Fully conserved residues are denoted with an (*).  Strongly 
conserved residues are denoted with (:), and weakly conserved residues are denoted with 
(.).  A BLAST comparison of the two PmtA sequences yields an e value of e=2x108, 
which indicates a high level of similarity[239-242]. The protein structure of P. 
aeruginosa PmtA has not been defined.  The structure of P. aeruginosa PAO1 PmtA (C) 
was predicted with protein threading, and the I-tasser protein prediction software. The 
sequence of PA01 PmtA was compared to the known sequence and structure of S. 
elongatus SmtA (B) (D.) The superposition of the proteins revealed PmtA PA01 had a 
helical region not present in SmtA of S. elongates. 
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3.2.2 The effect of P. aeruginosa PmtA on Jurkat T cell Chemotaxis  
 PmtA was expressed in Escherichia coli with a GST tag to facilitate purification 
with GSH-binding resin.  Therefore, all experiments using purified PmtA were compared 
to a GST control.   The concentrations of PmtA used in these experiments were chosen 
based on the concentrations of MT previously shown to produce a chemotactic response 
in Jurkat T cells [130].  
Jurkat T cells were exposed to SDF-1α, a member of the CXC family of 
chemokines, as a positive control, as well as PmtA and GST.   The Jurkat T cells were 
first exposed to these chemoattractants in the ECIS/Taxis system.  In this system, agarose 
fills a chamber of an ECIS/Taxis electrode, and two wells are cut in the agarose.  The cell 
well contains Jurkat T cells, while the opposite chemoattractant well contains SDF-1α, 
PmtA or GST. A target electrode that records the resistance at that electrode, separates 
the two wells.  As cells migrate from the cell well towards the chemoattractant, which 
forms a gradient through the agarose, the resistance at the target electrode increases.  This 
indicates the migration of cells toward chemoattractant [135, 137-140].   In this assay, 
only Jurkat T cells exposed to SDF-1α migrated across the electrode (Figure 3-4 A).  The 
Boyden Chamber assay was also used to measure chemotaxis of Jurkat T cells.  In this 
assay cells are separated from chemoattractants by a polycarbonate membrane with 5µm 
pores.  Cells that crawl toward the chemoattractant stick to the underside of the 
membrane and are stained and counted.  This assay reconfirmed that Jurkat T cells 
migrate only in the presence of SDF-1α, and do not chemotax to GST-PmtA or GST 
(Figure 3-4 B).   Although PmtA fails to induce chemotaxis of Jurkat T cells, the 
similarity to other MTs and chemokines still suggested that PmtA could modify cellular 
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movement.  Thus, we also evaluated PmtA’s influence on chemotaxis by incubating 
Jurkat T cells with PmtA prior to exposure to SDF-1α.  Jurkat T cells were incubated 
with PmtA or GST, and then exposed to SDF-1α in either the ECIS/Taxis system (Figure 
3-5, A) or the Boyden chamber (Figure 3-5, B).  In each of these assays Jurkat T cells 
pre-exposed to PmtA, but not GST, were found to lose the ability to migrate in the 
presence of SDF-1α.  Viability of cells after incubation with GST-PmtA or GST was 
evaluated with trypan blue stain.  Incubation with GST-PmtA or GST did not affect the 
viability of Jurkat T (Figure 3-6).  Therefore, the inability to migrate in response to SDF-
1α is not due to cell damage or death. 
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Figure 3.3 
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Figure 3.3: PmtA does not cause chemotaxis of Jurkat T cells in vitro.  A.) Jurkat T 
cells (2x106 cell/ml) were exposed to a gradient formed from a well containing either 
SDF-1α (25nM) GST (14µM) GST-PmtA (14µM) or RPMI in an ECIS/Taxis electrode. 
The change of resistance at 4000Hz was monitored over a 30 hour period.  Jurkat T cells 
did not migrate in response to either GST or GST-PmtA, but the SDF-1α elicited a robust 
response.  This is a result of triplicate chambers for each condition and is representative 
of 3 separate experiments.  B.) Jurkat T cells (2x106 cell/ml)  were exposed to either 
SDF-1α (25nM) GST (14µM) GST-PmtA (14 µM) or PBS for 4hr at 37°C in a transwell 
chamber.  Cells that traveled through the 5µm polycarbonate membrane were stained and 
counted on a microscope.  Jurkat T cells did not migrate in response to GST or GST-
PmtA, while a large number of cells migrated in response to SDF-1α.  This data is a 
result of 3 replicates and representative of at three separate experiments.  (KMP110113) 
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Figure 3.4 
 
Figure 3.4: Jurkat T cells incubated with GST-PmtA lose the ability to respond to 
SDF-1α.  Human Jurkat T cells (A. 2x106 cell/ml B. 4x106 cell/ml) were exposed to 
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GST-PmtA (14µM), GST (14µM) or RPMI media for 1 hour at 37°C and 5% CO2.  Cells 
were washed with fresh RPMI media.  A.) The cells were exposed to 12.5nM  SDF-1α  
in an ECIS/Taxis electrode at 37°C and 5% CO2.  The change of resistance at 4000Hz 
was measured over 35 hours. Jurkat T cells pre-exposed to GST-PmtA did not migrate in 
response to SDF-1α, while those exposed to GST migrated in response to the chemokine.  
Data is an average of three replicates and representative of 3 separate experiments. B.) 
Cells were exposed to 12.5nM SDF-1α or RPMI media in a transwell system for 4 hours 
at  37°C and 5% CO2.  Cells that traveled through the 5µm polycarbonate membrane 
were stained and counted on a microscope.  Cells that were exposed to GST-PmtA prior 
to exposure to SDF-1α in the transwell system lost the ability to response to SDF-1α.  
Data is the average of 5 wells and representative of 3 experiments (*=p<0.05) .  
(KMP050112, KMP053112) 
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Figure 3.5 
Figure 3.5: Incubation of Jurkat T cells with GST-PmtA and GST did not affect cell 
survival.  Jurkat T cells (1x105 cells) were treated with 5.6µM GST or 5.6µM  GST-
PmtA and subsequently treated with 12.5nM SDF-1α (A).   The survival of the Jurkat T 
cells was measured with trypan blue exclusion and compared to a control treated only 
with 12.5nM SDF-1α.  Jurkat T cells (1x105 cells) were treated with 5.6µM GST or 
5.6µM  GST-PmtA for 1 hour, and were not exposed to SDF-1α (B).  The survival of the 
Jurkat T cells was measured with trypan blue exclusion an compared to an untreated 
control. (KMP030414). 
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3.2.3 The effect of PmtA on Cell Surface Receptors  
 PmtA’s ability to block the chemotaxis of Jurkat T cells to of SDF-1α may lie in 
its interaction with the CXCR4 receptor.  When SDF-1α binds CXCR4 internalizes 
quickly and traffics back to the plasma membrane, or degrades in the lysosome.  In 
uniform concentrations of SDF-1α, the CXCR4 receptor internalizes and promptly 
degrades [126].  Improper internalization of the receptor interferes with controlled 
migration of the cell. IF PmtA interferes with internalization or surface expression of 
CXCR4 it may lead to uncontrolled cellular migration.  Therefore PmtA’s ability to block 
the CXCR4 receptor was examined.   
  Jurkat T cells  were incubated with PmtA or GST and labeled with anti-CXCR4 
antibody and a secondary FITC conjugated antibody were examined by flow cytometry.  
To determine if  PmtA had effects on other receptors or if effects were specific to 
CXCR4, surface expression of CD3 was examined in parallel with CXCR4.  Neither 
PmtA nor GST interfere with the detection of CXCR4 or CD3 on the surface of Jurkat T 
cells (Figure 3.6).  However, PmtA could interact with CXCR4 in a way that does not 
interfere with the epitope region of the primary antibody, but does interfere with SDF-1α 
signal transduction.   
 To determine if PmtA blocks SDF-1α-mediate signal transduction, Jurkat T cells 
were pre-incubated with PmtA or GST and then directly exposed to SDF-1α, which 
causes the internalization of CXCR4.  Cells incubated with GST or a vehicle control, and 
then SDF-1α, have a 40-50% decrease in surface fluorescent staining of CXCR4, while 
the surface fluorescence of cells incubated with GST-PmtA only decreases 20-25% 
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(Figure 3.7).  This suggests that PmtA blocks the SDF-1α induced internalization of 
CXCR4. PmtA may modify CXCR4 surface expression, which can result in changes to 
the signaling cascade involved in chemotaxis.  This was shown by both flow cytometery 
and fluorescence microscopy (Figure 3.7).  
 GST-PmtA and GST were incubated with Jurkat T cells at both 37°C  (Figure 
3.10)  with 5% CO2, and at 4°C (Figure3.11) to determine if GST and GST-PmtA 
interacted with cell surface receptors.  A primary anti-GST tag antibody was used tag 
GST-PmtA and detected with a secondary antibody labeled with alexafluor647.  It was 
determined that GST-PmtA could not be detected on the surface of the plasma 
membrane.  From previous experiments GST-PmtA affects Jurkat T cells at 
concentrations ranging from 5.4µM to 14µM.  Assuming that the interaction between 
GST-PmtA and CXCR4 has a Kd of 10-9 M, which is typical of ligand-receptor 
interactions, the high concentration of GST-PmtA used would drive the koff rate to less 
than 10 seconds.  Therefore it would be unlikely that the assay described here, that uses 
5.4µM GST-PmtA, would be able to measure GST-PmtA on the surface of Jurkat T cells. 
PmtA’s  ability to block the SDF-1α induced internalization of the CXCR4 
receptor may cause downstream effects on the signal transduction cascade.  SDF-1α is 
known to cause a very quick influx of calcium into the cell [126], which may be 
disturbed by the presence of PmtA.  Attempts to measure this phenomena were 
confounded by the rapid dissipation of the calcium influx.  The difference in the rate or 
amount of calcium influx between cells incubated with PmtA or GST could not be 
accurately assessed (data not shown).   
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SDF-1α is also known to cause the phosphorylation of MAP kinase ERK, which 
leads to transcriptional changes necessary for cells to migrate in the presences of SDF-1α 
[224].  Jurkat T cells were exposed to PmtA or GST, and subsequently exposed to SDF-
1α.  The phosphorylation of ERK was determined using flow cytometery.  Neither 
incubation with GST or GST-PmtA affects the phosphorylation of ERK (Figure 3.12).  
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Figure 3.6: PmtA does not change expression of cell surface receptors CXCR4 and 
CD3.  Jurkat T cells (1x105 cells) were treated with 5.6µM GST, 5.6µM  GST-PmtA, or 
0.75nM SDF-1α, and the surface expression of CXCR4 (A) and CD3 (B) was measured 
with flow cytometry. GST-PmtA did not affect expression of either surface receptor.  
Data presented as percent of an untreated control. 
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Figure 3.7  
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Figure 3.7: PmtA Blocks SDF-1α induced internalization of CXCR4. A.) Jurkat T 
cells (1x105cells) were treated with 5.6µM GST, 5.6µM GST-PmtA for 50 minutes at 
37°C and 5% CO2 and then exposed to 0.75nM SDF-1α and the surface expression of 
CXCR4 was measured via flow cytometry.   A.) Data was normalized to the amount of 
CXCR4 expression in Jurkat T cells that were not exposed to SDF-1α.  Data is 
represented at mean of 3 independent experiments  +/- SEM (*=p<0.05 one-tailed 
Student’s T test).  B.) Representative histogram from a single experiment. Jurkat T cells 
(1x105cells) were either left untreated (C and D), treated with 5.6µM GST-PmtA (E) or 
5.6µM GST (F) for 50 minutes at 37°C and 5% CO2.  Cell shown in panels B-D were then 
exposed to 0.75nM SDF-1α and the surface expression of CXCR4 was visualized by 
fluorescent microscopy.  G.  Quantification of fluorescence from 3 separate images of 
each condition, and at least 5 replicates.  (=p<0.05 two-tailed student’s T test). 
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Figure 3.8: PmtA was not found on the surface of Jurkat T cells incubated at 37°C.  
Jurkat T cells (1x105cells) were incubated with 5.6µM GST-PmtA or 5.6µM GST for 1 
hour at 37°C.  The cells were washed and probed with a primary anti-GST tag antibody, 
and a secondary anti-IgG antibody coupled to alexafluor647 (AF-647).  Surface 
fluorescence was measured via flow cytometery (10,000 events). Cells were gated on 
forward and side scatter (A), and the fluorescence (FL4) of this gated population was 
analyzed (B).  The geometric mean of fluorescence intensity of FL4H+ gate (C) was 
analyzed in with a students T test.  Neither GST nor GST-PmtA were present on the 
surface of the Jurkat T cells.  A-C were results of the negative untreated control.  
(KMP030314) 
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Figure 3.9
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Figure 3.9: PmtA was not found on the surface of Jurkat T cells incubated at 4°C.  
Jurkat T cells (1x105cells) were incubated with 5.6µM GST-PmtA or 5.6µM GST for 1 
hour at 4°C.  The cells were washed and probed with a primary anti-GST tag antibody, 
and a secondary anti-IgG antibody coupled to alexafluor647(AF-647).  Surface 
fluorescence was measured via flow cytometery (10,000 events). Cells were gated  on 
forward and side scatter (A), and the fluorescence (FL4) of this population was analyzed 
(B).  The  geometric mean of fluorescence intensity of G1 gate (C) was analyzed in with 
a students T test.  Neither GST nor GST-PmtA were present on the surface of the Jurkat 
T cells.  A-C were results of the negative untreated control.  (KMP030514) 
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Figure 3.10 
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Figure 3.10: PmtA does not affect the phosphorylation of ERK.  Jurkat T cells (1x105
 
cells) were treated with 5.6µM GST, 5.6 µM GST-PmtA or left untreated for 50 min.  
The cells were then washed and stimulated with 25nM SDF-1α for 15min.  Cells were 
subsequently fixed and permeablized.  Phosphorylation of p42/44 ERK was measured 
with flow cytometery.  Neither the GST or GST-PmtA treatments changed the levels of 
ERK phosphorylation.  A) Data is shown as the percent increase in ERK phosphorylation 
compared to a control population that was not stimulated with SDF-1α and is the mean 
+/-SD of 3 separate experiments.  B.) A histogram from a single experiment, 
representative of 3 separate experiments.  
 
 
  
   93
3.3 Discussion 
   
 This study suggests the immunomodulatory capacity of MT includes effects by 
both eukaryotic MT and bacterial MTs.  Conventionally, MTs are classified as stress 
response proteins that expressed in response to high concentrations of essential and heavy 
metals.  The ability of PmtA to disrupt mammalian cell movement suggests the study of 
bacterial MTs should encompass more than the ability to bind metals, similar to their 
eukaryotic counterparts.   
 Bacterial MT should be studied not only in the context of their 
immunomodulatory functions, but also as potential virulence factors for pathogens that 
express these proteins.  PmtA’s impact on mammalian cell movement may be 
advantageous to P. aeruginosa in infection.  The pathogen P. aeruginosa causes many 
nosocomial infections by colonizing burn victims, patients on ventilators, and patients 
with catheters.  P. aeruginosa lung infection often results in the death of people  with the 
genetic disorder cystic fibrosis (CF).  In CF patients, P. aeruginosa causes repeated acute 
infections, until it finally establishes a chronic lung infection that causes damage to lung 
epithelial cells [243].  In acute infections, resident progenitor epithelial cells constantly 
replace injured epithelial cells, but in chronic infections, resident progenitor cells cannot 
keep up with the rate of damage to these cells.  In this case, replacement of epithelial 
cells depends on the migration of circulating progenitor epithelial cells to the site of 
damage, through CXCR4/SDF1-α signaling [236].  The disruption of CXCR4/SDF1-α 
signal transduction could weaken the immune response to the pathogen, and the repair 
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mechanisms critical to lung structural integrity.  This could lead to a decrease in 
epithelial continuity and extensive damage to the lung.   
 In order for PmtA to disrupt the T cell migration during a lung infection there 
must be damage to the lung epithelium.  PmtA, which could be either secreted from 
bacterial cells, or released as a result of damage to bacterial cells during infection, would 
have to breach the epithelial barrier to reach T cells located in the lamina propria.  P. 
aeruginosa can attach to epithelial cells and destabilize the tight junctions, which would 
provide an exit for PmtA [166]. However it is more likely that PmtA can \ disrupt the 
migration of cells that are already in the lung, rather than be released from the lung and 
disrupt migration.  A T cell mediated response to P. aeruginosa infection is necessary for 
the management of chronic infections [183].  Once T cells reach the site of infection, 
PmtA could disrupt the migration of the T cells and the ability of the immune response to 
combat infections.  PMNs are another cell type that is very important for the clearance of 
P. aeruginosa.  PMNs must be successfully trafficked into the lung in order to aid in the 
clearance of an infection. Future experiments should focus on the ability of PmtA to 
disrupt the migration of these cell types, as this could further dampen the immune 
response to P. aeruginosa.  
 The decrease of SDF-1α-induced internalization of CXCR4 after incubation of 
PmtA indicates that the protein interferes with the Jurkat T cell’s desensitization to the 
SDF-1α signal.  PmtA’s interference with the CXCR4 internalization process indicates 
that the protein can alter migration patterns of immune cells by altering signal 
transduction at the receptor.  As indicated by trypan blue exclusion studies, the presence 
of PmtA or GST does not change the survival of the Jurkat T cells.  Additionally, 
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microscopic studies (data not shown) indicate that the morphology of the cells do not 
change with the addition of PmtA or GST.    
 The absence of PmtA on the surface of the cell at both 37°C and 4°C suggests that 
PmtA does not bind the receptor with high infinity.  As previously discussed, the 
millimolar concentrations of GST-PmtA used would push the ligand-receptor interaction 
rate to less than 10 seconds, which would not be measureable.  A better way to measure 
PmtA’s ability to bind CXCR4 would be a competition-binding assay with SDF-1α.  In 
this assay GST-PmtA would compete with SDF-1α for CXCR4 using either purified 
CXCR4 or whole Jurkat T cells both immobilized on a column.  A known concentration 
of SDF-1α would be added to the immobilized receptor or cell and varying 
concentrations of GST-PmtA would be subsequently added.  The column would then be 
washed and the elute collected.  The concentration of SDF-1α in each elute could then be 
measured by ELISA.  This would determine what concentration of GST-PmtA, if any, 
could displace SDF-1α from the receptor.  
It is possible that PmtA would not be found on the surface of Jurkat T cells, and 
does not bind the CXCR4 receptor.  PmtA could be internalized by the cell and affect the 
cell’s ability to transduce intracellular signals.  If the cell internalizes PmtA the thiol 
group present on the numerous cysteine residues of PmtA can oxidize and alter 
intracellular redox environment and, in turn, modify redox sensitive signaling.  T cell 
migration depends on the uptake of H2O2.  Activation of the Rho family GPTase Cdc42 
requires the transport of H2O2 [244].  Mice that lack the ability to mediate the transport of 
H2O2 are deficient in trafficking of antigen primed T cells in response to SDF-1α [244].  
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The numerous thiol residues on PmtA could change the transport of ROS and impair the 
movement of Jurkat T cells. 
Other cells, such as prostate cancer cells also rely on ROS to transmit intracellular 
signals after the binding of SDF-1α to the CXCR4 receptor.  In vitro experiments with 
prostate cancer cells reveal that an increase in ROS results in an increase in migration.    
Additionally, the binding of SDF-1α to CXCR4 promotes intracellular ROS 
accumulation [245].  The addition of the antioxidant N-acetyl-cysteine (NAC) decreases 
the ability of prostrate cancer cells to migrate in response to SDF-1α in vitro.  The main 
NADPH oxidase involved in the production of ROS upon SDF-1α binding to CXCR4 is 
NOX2.  If NOX2 is blocked, cells do not migrate in response to SDF-1α [246].  This 
indicates that intracellular ROS produced upon the binding of SDF-1α to CXCR4 is 
necessary for cell migration.  The cysteine residues present on PmtA suggest that it could 
work as an antioxidant.  This may be a possible mechanism for the decrease in migration 
observed when cells are treated with GST-PmtA.  The GST-PmtA could bind a receptor 
and become internalized, which could deplete the intracellular pool of ROS and decrease 
migration (Figure 3.11).   This can be tested in the future by measuring the intracellular 
pool of ROS with the oxidant sensitive probe H2DCFDA.  Despite the ability of GST-
PmtA to disrupt migration, it did not have an impact on ERK phosphorylation (Figure 
3.10).  This is consistent with the model that suggests PmtA works as an antioxidant 
since ERK phosphorylation in conjunction with SDF-1α binding to CXCR4 is and ROS 
independent process [247]. 
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If PmtA is able to act as an antioxidant, it could have a global effect on ROS-
reliant processes.  For example, this study showed that the expression of CD3 on the 
surface of Jurkat T cells did not change with the addition of GST-PmtA.  However, these 
studies did not address the effect of GST-PmtA on the activation of Jurkat T cells, which 
relies on ROS-mediated signals.  In the future, GST-PmtA’s ability to affect T cell 
activation should be studied.   
 Taken together, the results of this study suggest that P. aeruginosa PmtA could 
influence the course of an infection.  Further study is needed to determine if the loss of 
migration due to the addition of PmtA is a global phenomena, or specific to CXCR4 
signaling.  The addition of PmtA may contribute to the redox sensitive signaling in 
immune cells.  Overall these results suggest PmtA contributes to immune cell processes, 
which may make it a candidate for the development of a novel therapeutic intervention to 
P. aeruginosa.  
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Figure 3.11 
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Figure 3.11 Proposed model for PmtA induced inhibition of Jurkat T cell 
Chemotaxis.   Based on information in previous studies, it can be proposed that 
PmtA is internalized by Jurkat T cells which allows it to deplete the pool of 
intracellular ROS produced upon the binding of SDF-1α to CXCR4.  As seen in other 
studies, this would inhibit the migration of Jurkat T cells in response to SDF-1α.   
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CHAPTER 4: EXPRESSION OF PMTA INFLUENCES P. 
aeruginosa VIRULENCE 
 
4.1 Introduction 
 Previous work presented in chapter 3 suggests that PmtA can modulate the 
immune system and thus the virulence of P. aeruginosa.  P. aeruginosa expresses many 
known virulence factors, but the function of PmtA during P. aeruginosa infection has yet 
to be studied.  If PmtA expression affects growth in the presence of stressors that are 
representative of the stressors present during infection it is reasonable to predict that 
PmtA may influence P. aeruginosa virulence in vivo.  If PmtA is indeed a virulence 
factor, it could serve as a novel therapeutic target for an increasingly antibiotic-resistant 
human pathogen. 
 
4.1.1 P. aeruginosa: An important infections agent  
  The opportunist pathogen, P. aeruginosa ranks among the top 5 organisms 
causing pulmonary, bloodstream, urinary tract, surgical site, and tissue infections [248].  
The well-known nosocomial infection plagues patients on ventilators, those with 
catheters, or serious burns[249, 250].  This pathogen often colonizes the lungs of 
immunologically compromised people, such as those with cystic fibrosis (CF).  For CF 
patients, P. aeruginosa causes massive chronic infections, and many times, death [251].  
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Conventional treatment of P. aeruginosa involves heavy doses of antibiotics.   
However, the pathogen can respond to antibiotic treatment through the expression of 
efflux pump systems that allow the bacteria to remove intracellular toxins like antibiotics 
[252, 253].  The ability of the pathogen to expel antibiotics and easily adapt to adverse 
environments has resulted in the increase in antibiotic-resistant strains of P. aeruginosa 
[254, 255].  The study of virulence factors that allow P. aeruginosa to colonize an 
immunologically compromised host can lead to the development of new innovative 
treatments.   
  
4.1.2 Expression of Pseudomonas aeruginosa Virulence Factors 
P. aeruginosa possesses a large bacterial genome that provides the pathogen with 
many metabolic options, and allows it to adapt to many environments  [256, 257].   
Constitutive transcription of the full genome would be metabolically inefficient.  Bacteria 
use environmental cues to determine which portions of the genome to transcribe.  One 
methods P aeruginosa uses to efficiently transcribe its genome is quorum sensing. 
therefore, the bacteria employ quorum sensing to transcribe the most useful genes for the 
current environment.  
 
4.1.3 Quorum Sensing  
 Quorum sensing (QS) is a method of cell-to-cell signaling that involves freely 
diffusible molecules called autoinducers (AIs) [258-260].  As the cell density of P. 
aeruginosa increases, the AI concentration increases, which in turn modifies gene 
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expression.  In a traditional luxI/LuxR QS system, LuxI synthesizes the AI that is 
detected by LuxR. The LuxI-AI complex activates transcription of target genes.  One of 
the target genes of the LuxI-AI complex is the luxI gene, which in turn synthesizes more 
AI and creates a positive feedback loop. It is estimated that QS controls the expression of 
10% of the P. aeruginosa genome. [261].     
 P. aeruginosa uses three QS systems, 2 LuxI/LuxR systems and 1 Pseudomonas 
quinolone signal (PQS) system [261].  In the LasI/LasR system, LasI synthesizes 3-ox-
C12 homoserine lactone, which serves as an AI and is detected by LasR.  The LasI-3-ox-
C12 homoserine lactone complex increases the transcription of virulence genes as well as 
lasI [261-263].  The second LuxI/LuxR system, which uses RhlI/RhlR, works in the same 
manner but uses butanoyl homoserine lactone as its AI [264, 265].  It also controls the 
transcription of several virulence genes, such as those that control the production of 
pyocyanin [266].  The PQS system uses PsqA,B,C,D and H, which are detected by PqsR.  
Unlike the LuxI/LuxR-like systems, the expression of the PQS inducers are activated by 
LasR-AI complex and repressed by the RhlR-AI complex.  The overlap of the QS 
systems allows for differential expression of virulence factors in diverse environmental 
conditions [261, 267-270].  In infection, P. aeruginosa uses QS to form a biofilm that 
allows the bacteria to persist in harsh conditions 
 
4.1.4 Biofilm 
 When in a biofilm, a community of microbial cells attaches to a surface and 
secrete exopolysaccharide [271].  Microbial cells in a biofilm alter their metabolic 
activity, as well as their gene and protein expression.  This metabolic shift allows the 
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bacteria to efficiently transcribe its genome and persist in its current environment.  In a P. 
aeruginosa infection, biofilm formation contributes to the development of chronic 
infections, such as the infections that can occur in CF patients [272].  When in a biofilm 
P. aeruginosa produces the exopolysaccharide alginate, which serves as a barrier that 
protects the bacteria from immune cells, ROS, and antibiotics [271, 273].   
 The production of alginate converts P. aeruginosa to a mucoid phenotype, 
defined by the secretion of exopolysaccharides[274].  As the organism reaches a high 
density it converts to a mucoid producing strain is associated with a poor prognosis and is 
often observed in the infected lung of a CF patient post mortem [275].  Compared to non-
mucoid strains, mucoid strains of P. aeruginosa are more difficult to clear and result in 
severe lung damage[276].  The mucoid matrix associated with the biofilm further protects 
the bacteria from phagocytosis by immune cells and increases resistance to antibiotics 
[277].  In murine models of chronic P. aeruginosa infection neutrophils surround the 
mucoid-producing biofilm, but phagocytose very few bacteria[278, 279].  This indicates 
that immune cells can do little to eliminate mucoid-producing strains of P. aeruginosa.  
In addition to alginate, P. aeruginosa in a biofim also expresses elastase and alkaline 
protease to prevent damage from host immune cells [280-283].  A therapy that blocks 
biofilm formation and mucoid conversation coupled with antibiotic therapy could 
increase the effectiveness of antibiotics against P. aeruginosa.   
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4.1.5 Type III Secretion System and Its Toxins 
 P. aeruginosa uses a Type III Secretion System (TTSS) to deliver 4 different 
effector toxins to host cells.  The TTSS is essential to the pathogenesis of this organism, 
as neutralization of the TTSS prevents sepsis and improves survival of the host in animal 
models [284]. The TTSS delivers the toxins ExoS, ExoT, ExoU, and ExoY directly to 
host cells through a needle-like protrusion that extends through the host plasma 
membrane [285].  
ExoS acts as GTPase-activating protein (GAP) with a Adenosine diphosphate 
(ADP)-ribosylating function [286].    GAP proteins regulate GTP binding proteins that 
control cell growth, differentiation and apoptosis.  The N-terminus of ExoS is a Rho-
specific GAP that interferes with G-protein signaling of host cells.  The ExoS C -
terminus can ADP-ribosylate host proteins and interfere with cell signaling transduction 
[287, 288].  ExoT also functions as a GAP and ADP-ribosylating protein.  The ADP-
ribosylating activity of ExoT depolymerizes the actin cytoskeleton [289].  ExoT injection 
causes cells to round, which can affect junctions between host cells as well as cell 
movement [290].   ExoU can irreversibly damage the tight junctions between epithelial 
cell membranes.  The C-terminus of ExoU associates with plasma membrane 
phospholipids and the enzymatic activity of ExoU cleaves the phospholipids [291-294].  
ExoU is essential to the virulence of P. aeruginosa in murine infection models and is 
present in 90% of all human infection [285].  The mechanisms of the second adeylate 
cyclase, ExoY are not as well characterized.  Injection of ExoY elevates intracellular 
cAMP and disrupts the transcription of genes associated with actin cytoskeleton 
polymerization [285].  The disruption of the actin cytoskeletal polymerization by many of 
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these toxins leads to a decrease in the ability of the host to phagocytose bacterial cells, 
traffic to sites of infection and also increases cellular permeability [295]. 
P. aeruginosa also produces other proteins and metabolites that contribute to its 
virulence, but are not delivered through the TTSS, such as siderophores, elastase, alkaline 
proteases, hemolysins, cytotoxins, and pyocyanin [296].   The virulence factors expressed 
by P. aeruginosa affect a wide array of targets.  QS allows the bacteria to efficiently 
express these virulence factors and adapt to certain conditions.  The TTSS allows the 
bacteria to efficiently deliver toxins inside the host cells.   Taken together, these 
characteristics give P. aeruginosa an enormous advantage in the colonization of an 
immune-compromised host and create challenges in the treatment of P. aeruginosa. 
 
4.1.6 Pyocyanin 
P. aeruginosa synthesizes a toxic blue heterocyclic phenazine  from chorismic 
acid, called pyocyanin. The color of pyocyanin differs in reduced and oxidized states.  
Reduced pyocyanin is colorless, while the oxidized form turns blue [297].  In culture P. 
aeruginosa secretes pyocyanin into the medium during the stationary phase of bacterial 
growth [298]. (Figure 4.3).  The highly diffusible pigment passes easily through host cell 
membranes where it changes to the redox environment of the cell and interferes with host 
cell respiration, electron transport, gene expression and immune function [297, 299, 300].  
These effects on host cell metabolism and function allows the bacteria to manipulate the 
inflammatory environment and increase the survival and persistence of the pathogen.   
Pyocyanin acts predominately as a redox sensitive molecule in P. aeruginosa lung 
infections. The ability of the metabolite to easily cross cell membranes allows it to 
   106
interact with NADPH of host cells.  Pyocyanin oxidizes reduced NADPH and donates 
accepted electrons to oxygen to produce superoxide, which is converted to H2O2 [298].  
H2O2 can then affect cell signaling and damage cellular components.  Pyocyanin also 
allows H2O2 to persist in the environment, which further manipulates redox-sensitive 
signaling and damages cells.   Pyocyanin inhibits the host cell expression of the 
antioxidant enzyme catalase that breaks down H2O2 [301].  This further increases H2O2-
induced oxidative damage to the host cell, which aids in the persistence of the pathogen.  
The increase in intracellular ROS levels also results in a decrease of ATP synthesis and a 
decrease in GSH [297].    
In the context of a biofilm, pyocyanin surrounds the P. aeruginosa biofilm and 
creates a redox-potential gradient.  The reduced state protects bacteria in the biofilm from 
exogenous oxidant.  The pyocyanin redox-potential gradient also enriches the 
environment with iron, which is essential to biofilm formation and stability [302].     
Pyocyanin decreases the survival of neutrophils, an immune cell type essential to 
the elimination of P. aeruginosa. In vitro, incubation of neutrophils with concentrations 
of pyocyanin, comparable to the pyocyanin concentrations found in the sputum of CF 
patients, increases apoptosis of the cells, when compared to untreated counterparts  [303].  
Pyocyanin induced neutrophil apoptosis can be partially blocked by some antioxidants, 
which indicates exposure to pyocyanin induced oxidant causes neutrophil cell death. 
[303].  Neutrophils produce superoxide that usually dissipates quickly, forming the 
antimicrobial intermediate H2O2.  Pyocyanin prolongs the production of superoxide, 
which increases the generation of H2O2 [303].  Exposure of neutrophils to pyocyanin 
elevates diacylglyceride levels, which induces NADPH-activity [304].   This leads to an 
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increase in superoxide and oxidant-induced damage to host cells, as pyocyanin also 
decrease the expression of host oxidant defenses [305]. 
During an in vivo P. aeruginosa infection, more neutrophils undergo apoptosis in 
mice infected with a wildtype strain of the bacteria than in mice infected with a strain of 
P. aeruginosa that lacks genes necessary for phenazine production and is thus pyocyanin-
deficient.  The mice infected with wildtype P. aeruginosa produced less neutrophil-
dependent chemokines than those infected with the pyocyanin-deficient strains. This 
decrease is thought to be beneficial to the pathogen, [306] and indicates that pyocyanin 
inhibits the immune response to the pathogen and increase its virulence.  
Pyocyanin also affects the ability of another professional antigen-presenting cell 
(APC) cell type to eliminate P. aeruginosa infection.  Exposure of macrophages to 
pyocyanin decreases the ability of the macrophage to phagocytose bacteria and cell 
debris.   Addition of antioxidants partially rescues the phagocytic capabilities of 
macrophages in the presence of pyocyanin [307].  The ability of pyocyanin to interfere 
profoundly with the functions of neutrophils and macrophages underscores the role 
played by that pyocyanin as a significant virulence factor.   
 Pyocyanin affects host cell gene expression through the induction of IL-8, 
ICAM1, CXCL1, CXCL2, and CXCL3  genes [308-310].  These genes are involved in 
directed cell migration and recruitment of immune cells to the sites of infection.   In a 
lung infection, pyocyanin exposure also leads to the increase in the expression of five 
host mucin genes MUC5B, MUC20, MUC13, MUC2, and MUC5ac in cells that 
comprise the airway epithelium [308].  The expression of these genes allows for the 
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secretion of mucin, a glycol protein, by the airway mucosa [311].  Under normal 
conditions, mucin protects the airway epithelium from pathogens and debris, but the 
increase in expression of these results in genes-overproduction of mucin and airway 
obstruction [311].  The increase in mucin in the airway also leads to an increase in 
bacterial attachment to the epithelium [312] 
4.1.7 Production of the PmtA deficient P. aeruginosa strain PW4670 
 The Manoil Laboratory at the University of Washington constructed a two-allele 
transposon library using P. aeruginosa PAO1 as the parent strain.  The mutants from the 
primary transposon library carry either the ISlacZ/hah or the ISphoA/hah transposon.  
Eeach of these transposons carry a tetracycline resistance gene.  The strains for the two-
allele library were chosen from the primary library based on the insertion of the 
transposon into two sites of the same gene (where possible) the location of the insertion 
site in the middle of the gene, and in frame insertion of the transposon [313].  The two 
different insertion sites provide redundancy of the mutation, in which phenotypes can be 
verified with two distinct mutants.  The PmtA gene is known as a probable 
metallothionein encoded by the ORF PA2140.  There was only one transposon insertion 
site for this mutant and thus only one distinct mutant in the library known as strain 
PW4670.  There is likely only one insertion site for transposon due to the small 240bp 
length of the ORF PA2140 (Figure 4.1). 
 After exposure to the transposon, bacteria were grown in the presence of 
tetracycline, as the bacteria should gain tetracycline resistance upon insertion of the 
transposon.  Single colonies were isolated, grown up and the insertion of the transposon 
was confirmed using two different methods.  The first was conventional DNA sequence, 
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known as Sanger sequencing, and the second was Tn-seq analysis.  Tn-seq is a sensitive 
method to determine genetic interaction in mircoorganisms through massive parallel 
sequencing [314].  In Tn-seq an endonuclease site is incorporated into the end of the 
transposon and cuts 20bp downstream from the site [315].  Sequencing the DNA from the 
ends of the transposon, and the additional 20bp of flanking DNA is enough to determine 
the location of the transposon in the bacterial genome [316]. 
 The Manoil laboratory confirmed the position of the ISphoA/hah transposon in 
PW4670 to be at base pair 108 of 240 through both Sanger sequence and Tn-Seq.  The 
insertion of the transposon in the middle of the gene ensures that if any protein is still 
translated it is unlikely to have any biological affect. The insertion of the transposon was 
again confirmed with PCR (Figure 4.2). 
 
Figure 4.1: Position of the ISphoA/hah transposon in ORF PA22140. The 4.83kb 
transposon was incorporated into the PAO1 genome with the methods described after 
base pair 108.  The incorporation of ISphoA/hah into the PA2140 ORF, responsible for 
the transcription of PmtA, is present in P. aeruginosa strain PW4670.  
 
 
 PA2140 PA2140ISphoA/hah
4.83kb
1bp to 108bp 109bp to 240bp
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4.1.8 Hypothesis: The Absence of PmtA Expression in PW4670 will decrease the 
virulence of P. aeruginosa 
 The P. aeruginosa strain PW4670, derived from the PAO1 strain fails to express a 
fully functional PmtA protein due to the insertion of a transposon into the gene sequence.  
Strain PW4670 can be used to determine the function of PmtA in P. aeruginosa growth 
and infection.  The absence of an PmtA is likely to alter P. aeruginosa resistance to 
metals stress and ROS, and alter the expression of oxidant sensitive virulence factors.  
 In the presence of oxidative stress eukaryotic cells upregulate expression of MT to 
protect the cell from the oxidative stress [106].  The cysteine residues on PmtA suggest 
that this protein can also act as an antioxidant in P. aeruginosa.  If PmtA protects P. 
aeruginosa from oxidative stress it could enhance the survival of the bacteria in an 
infection.  Professional phagocytic cells produce ROS to damage bacterial cells and 
eliminate an infection.  The absence of a function PmtA protein could leave P. 
aeruginosa vulnerable to exogenous oxidative stress.   
 The absence of PmtA may also affect P. aeruginosa’s production of pyocyanin.  
In order to produce an oxidant to damage host cells P. aeruginosa must be able to protect 
itself through the production of antioxidants. Without the expression of PmtA, P. 
aeruginosa may decrease pyocyanin production to protect itself from oxidant, and thus 
decrease the virulence of the pathogen.    If PmtA acts as an antioxidant, the absence of 
the protein could affect other aspects of bacterial growth, such as the formation of a 
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biofilm.  This could leave the bacteria susceptible to phagocytosis by immune cells, may 
be inhibited.  This would again suggest that PmtA is needed for full virulence of the 
pathogen.   
 The functions of PmtA in the growth of P. aeruginosa was studied through the 
comparison of the wildtype PAO1 strain to the PmtA deficient strain PW4670.   
 
4.2 Results 
4.2.1 Confirmation of Transposon Insertion 
 In order to elucidate the function of PmtA on P. aeruginosa a strain with a 
transposon inserted into the gene that encodes for PmtA was obtained from the Manoil 
Laboratory at the University of Washington.  PW4670 was grown up in YTA broth 
streaked on YTA agar with 5µg/ml tetracycline. Single colonies were isolated and the 
presence of the transposon insertion was confirmed with PCR.  The insertion of the 
transposon into the PmtA gene was confirmed using PCR with the appropriate primers 
suggested by the Manoil Laboratory (Table 4.1). PCR conditions were optimized with 
GoTaq mastermix. (Figure 4.2A).  The PCR reaction that amplified wildtype PAO1 DNA 
with PmtA forward and reverse primers yielded an 833bp product, which indicates the 
PmtA gene is intact (Figure 4.2B Lane 1).  The insertion of the transposon in PW4670 
was confirmed by amplification of the PW4670 DNA with the PmtA reverse primer and 
the Hah-138 transposon specific primer.  This reaction yielded a 375bp product, which 
confirms the insertion of the transposon is in the predicted portion of the gene (Figure 
4.2B Lane 4).  As expected, negative controls that amplified PAO1 DNA with PmtA 
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reverse and Hah-138 primers and PW4670 DNA amplification with PmtA forward and 
reverse primers did not yield PCR products (Figure 4.2B, Lanes 2 and 3).  
 
 
Amplification Region Primer name Sequence 5’ - 3’ 
PmtA Forward 54742R.f GGTGTCGGTACCGGTGTTC 
PmtA Reverse 
 
54742R.r 
 
GCAGTACAGGATTCCGCAGT 
ISphoA/hah Transposon Hah-138 CGGGTGCACTAATATCGCCCT 
 
Table 4.1: Primers used for the confirmation of the ISphoA/hah Transposon 
Insertion.  The Manoil laboratory at the University of Washington designed all three 
primers used to confirm the insertion of the ISphoA/hah transposon in the PmtA gene.  A 
PCR reaction with PmtA Forward and PmtA Reverse Primers and wildtype PAO1 DNA 
as a template should yield an 833 bp product.  The insertion of the 4.83Kb transposon in 
the PmtA gene to create strain PW4670 would not yield a product with the PmtA forward 
and reverse primers, but would yield a 375bp product with the PmtA reverse and Hah-
138 primers.    
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Figure 4.2 
 
500bp
800bp
400bp
A. 
B. 
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Figure 4.2: PCR confirmation of Transposon Insertion into the PmtA Gene.  A.) The 
PCR cycle was optimized for temperature, as well as DNA concentration.  This PCR 
cycle was used to confirm the insertion of the ISphoA/hah transposon into the PmtA 
gene.  B.) The optimized PCR reaction was run with combinations of the PmtA specific 
forward and reverse primers, as well as PmtA reverse and hah-138 primers, with DNA 
extracted from PAO1 and PW4670.  The wildtype DNA yielded the predicted full 833bp 
product with the PmtA forward and PmtA reverse primers.  PW4670 yielded a 375bp 
product, which indicates the insertion of the transposon in the PA2140 gene.  
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4.2.2 Growth Curves of PAO1 and PW4670 
 PAO1 and PW4670 were grown overnight at 37°C with vigorous shaking in YTA 
media or YTA media with tetracycline, respectively and transferred to fresh YTA media 
without antibiotics at a dilution of 1:100.  The strains were incubated at 37°C with 
vigorous shaking for up to 1800 minutes.  Bacterial growth was measured with 
absorbance readings at 600nm.  No measurable difference between the growth of the two 
strains was observed. (Figure 4.3).  
 Although there was no measureable difference between PAO1 and PW4670 at 
OD600nm there was a visible difference in the appearance of the two strains.  After 30 
hours of growth, the media of the wild type PAO1 strain appeared green, while the 
PW4670 remained yellow (Figure 4.4A).  Pyocyanin, a toxic secondary metabolite 
secreted by PAO1, creates the green color in the media. 
 
4.2.3 Pyocyanin Production in PAO1 and PW4670 
 The toxic metabolite pyocyanin contributes to the overall virulence of P. 
aeruginosa.  A deficiency of the PW4670 strain to produce pyocyanin would suggest that 
PmtA expression is necessary for the full virulence of the pathogen.   In culture, 
expression of pyocyanin increases during stationary phase growth.  The presence of 
pyocyanin in the cell-free supernatants of both PAO1 and PW4670 was measured at an 
absorbance of 691nm after 30 hours of growth and plotted as a ratio of 600nm to 691nm 
(Figure 4.5A).   Cell-free supernatant from PAO1, collected from stationary phase 
cultures, consistently contained more pyocyanin than PW4670.  
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 To confirm that the 691nm readings specifically measured pyocyanin in the 
supernatant and that the difference in 691nm absorbance readings was not due to the 
presence of pyocyanin in the colorless reduced state, pyocyanin was extracted from the 
supernatants after 30 hours of growth with a chloroform/HCl extraction [317, 318].  The 
absorbance at 691nm of both supernatants was recorded prior to the extraction (Figure 
4.5,A-B). In the first portion of the extraction, chloroform was added to the PAO1 and 
PW4670 supernatants, which produced a blue product. When blue in color, the pH of 
pyocyanin in solution is 6 to 7, and the absorbance can be measured at 300nm (Figure 
4.5, C-D).  HCl was then added to the extractions, which lowers the pH of pyocyanin in 
solution to 1 to 2 and turns the pyocyanin pink.  The absorbance was measured at 520nm 
(Figure 4.5, E-F).  At all points in the extraction, the absorbance readings for PAO1 were 
higher than PW4670.  This suggests the 691nm absorbance readings adequately measure 
the pyocyanin levels in the supernatant of both PAO1 and PW4670.   
   If PmtA acts as an antioxidant in the P. aeruginosa cell, the decrease in 
pyocyanin production may be because the bacteria lacks protection from oxidant without 
the expression of PmtA.  The addition of an antioxidant in the media may rescue the 
pyocyanin expression in strain PW4670.  The antioxidant glutathione at 10mM was 
added to the media of the PW4670 strain of P. aeruginosa, and pyocyanin production 
was measured overtime with absorbance readings of the cell-free supernatants at 691nm.  
The addition of glutathione rescued the pyocyanin production in strain PW4670 (Figure 
4.6).  The ability of another antioxidant, N-acetylcysteine (NAC), to rescue pyocyanin 
production in Pw4670 was also measured.  Similar to glutathione, the addition of NAC 
increased pyocyanin expression in PW4670, after 30 hours of incubation  (Figure 4.7).  
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The ability of these antioxidants to rescue pyocyanin production indicates that the genes 
necessary to produce pyocyanin are not interrupted in the mutant.  It also suggests PmtA 
acts as an antioxidant, and the lack of this antioxidant decreases the expression of one of 
the pathogen’s essential virulence factors.   
 
 
 
 
 
 
   118
 
Figure 4.3: PAO1 and PW4670 strains of P. aeruginosa grow at similar rates 
Both the wildtype PAO1 strain and PW4670 strains were grown overnight at 37°C with 
vigorous shaking by inoculating 5ml of YTA or YTA with tetracycline for PW4670 with 
a single colony from a streak plate.  Fresh YTA (25ml) without antibiotics was then 
inoculated at a dilution of 1:100 with the overnight cultures and incubated at 37°C with 
vigorous shaking for 30 hours.  Absorbance readings at 600nm were recorded every hour 
during log phase (B-D), and then again overnight, until the 30 hour time point (A).  No 
difference in growth rate was observed between the strains.   
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Figure 4.4 
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Figure 4.4: P. aeruginosa strain PW4670 fails to turn culture supernatant green, 
which indicates a lack of pyocyanin production.  
Both the wildtype PAO1 strain and PW4670 strains were grown overnight at 37°C with 
vigorous shaking in either 5ml of YTA or YTA with tetracycline, respectively.  Fresh 
YTA (50ml) without antibiotics was then inoculated at a dilution of 1:100 with the 
overnight cultures and incubated at 37°C with vigorous shaking for 30 hours. It was 
observed that after 30 hours the supernatant of PW4670 did not turn green while PAO1 
supernatant was green (A).  The green color in observed in the supernatant of many P. 
aeruginosa strains is due to the redox sensitive metabolite pyocyanin.  (B) The structure 
of pyocyanin.     
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Figure 4.5: The supernatant of P. aeruginosa strain PW4670 contains less pyocyanin 
than strain PAO1.   
P. aeruginosa strains PW4670 and PAO1 were grown in YTA media for 30 hours at 
37°C with vigorous shaking .  At 30 hours, cell-free supernatant was collected through 
three consecutive centrifugations at 13,200rpm for 90s.  In media, the absorbance of 
pyocyanin can be measured at 691nm (A-B).  Pyocyanin was then extracted from the 
media supernatant with chloroform and HCL, using an established protocol.  The 
supernatant was first vigorously vortexed with chloroform, which yielded a blue 
pyocyanin layer, that absorbs at 300nm (C-D).  The blue pyocyanin layer was then 
exposed to HCl, which dropped the pH of the extract to ~2, and formed a pink layer that 
absorbs at 520nm (E-F).  In all portions of the extraction, the pyocyanin levels of the 
wildtype PAO1 were higher than PW4670. *=p<0.05 according to a student’s T test. 
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4.2.4 The Contribution of PmtA expression on P. aeruginosa Virulence 
 The lack of PmtA expression contributes to the decrease in pyocyanin expression, 
and may, therefore, contribute to the overall virulence of the pathogen.  The murine 
alveolar macrophage cell line, MH-S, was exposed to dilutions of cell-free supernatants 
from 30-hour cultures of either PAO1 or PW4670.  The cells that survived the after 30 
minutes of exposure to PAO1 or PW4670 supernatants were counted and the cell number 
was compared to an untreated control to obtain the percent survival of each group.  The 
PAO1 supernatant killed significantly more macrophages in all supernatant dilutions 
(Figure 4.8).  
 The virulence of the supernatant was further tested with a Galleria mellonella 
wax worm larvae model.  In this model, larvae were injected with 5µl of cell-free 
supernatant from either PAO1 or PW4670 obtained after 30 hours of growth.  The 
survival of the larvae was recorded after 24 hours.  Three separate experiments were 
combined to increase the sample number, and an odds ratio was calculated.  It was 
determined that death was 7.48 times more likely if the larvae were injected with PAO1 
supernatant than PW4670 supernatant (Figure 4.9 A).  This indicates that PAO1 
supernatant is more likely to kill the larvae than PW4670 supernatant in vivo.  The 
supernatants were dialyzed against PBS using a 3,000 to 6,000 Dalton dialysis membrane 
in order to dialyze out the pyocyanin but not small proteins such as PmtA.  The dialyzed 
supernatants were than injected into the G. mellonella larvae and incubated at 25°C for 
24 hours.  After the supernatants were dialyzed, neither PAO1 nor PW4670 supernatant 
killed the larvae in 24 hours.  This indicates that the lethal effects of the PAO1 
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supernatants can be attributed to a small molecule such as pyocyanin and not the PmtA in 
the media (4.9B).  
 
4.2.5 The Contribution of PmtA expression on P. aeruginosa Biofilm Formation 
 The formation of a biofilm is crucial to the virulence of P. aeruginosa.  Strains 
that form a biofilm secrete the exopolysaccharide alginate associated with the 
conversation to a mucoid-producing strain, and a poor prognosis for patients [274, 275].   
The contribution of PmtA expression on the formation of a biofilm was determined a 
microtiter plate biofilm formation assay [187].  An inhibition in biofilm formation was 
observed in the PmtA-deficient strain, PW4670 compared to the wildtype PAO1 strain 
(Figure 4.10).   The addition of the antioxidant, GSH, did not rescue biofilm formation, as 
it rescued pyocyanin expression (Figure 4.10).   This indicates that the inhibition of 
biofilm formation in PW4670 is likely due to a mechanism unrelated to oxidative stress.  
The inhibition of biofilm formation may contribute to the overall virulence of P. 
aeruginosa strain PW4670. 
 
4.2.6 Growth of PAO1 and PW4670 in the presence of Hydrogen Peroxide 
 The decrease in pyocyanin production PW4670, and its subsequent rescue with 
antioxidants suggests PmtA acts as an antioxidant much like its eukaryotic MT 
counterpart.  To determine if PmtA expression protects P. aeruginosa from exogenous 
oxidant, both the wildtype PAO1 strain and the PmtA deficient PW4670 strain were 
grown to mid-log phase growth and subsequently exposed to 10mM H2O2.  There was no 
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difference in the survival or subsequent growth between PW4670 and PAO1 upon 
treatment with H2O2.  These results indicate that PmtA does not protect against 
exogenous H2O2, as was hypothesized (Figure 4.11). 
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Figure 4.6 
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Figure 4.6: The Addition of the Antioxidant Glutathione Restores Production of 
Pyocyanin in P. aeruginosa strain PW4670.  P. aeruginosa strains PAO1, PW4670 and 
PW4670 supplemented with 10mM glutathione (GSH) were grown in YTA media for 30 
hours at 37°C with vigorous shaking.  Over the 30 hour period, the growth of the bacteria 
(OD600) was compared to the production of pyocyanin in media (OD691).  A.) The 
PAO1 produced more pyocyanin when compared to PW4670 B.) When PW4670 was 
supplemented with the antioxidant GSH, pyocyanin production was restored to near wild 
type levels after 30 hours of growth (B).  These results are plotted as mean+/- SD and 
representative of three separate experiments.  
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Figure 4.7: The Addition of the Antioxidants Glutathione and N-acetylcysteine 
Restores Production of Pyocyanin in P. aeruginosa strain PW4670.  P. aeruginosa 
strains PAO1, PW4670 and PW4670 supplemented with 10mM glutathione (GSH) or 
1mM N-acetylcysteine (NAC) were grown in YTA media for 30 hours at 37°C with 
vigorous shaking.  Over the 30 hour period, the growth of the bacteria (OD600) was 
compared to the production of pyocyanin in media (OD691).  The PAO1 produced more 
pyocyanin when compared to PW4670.  The pyocyanin production of PW4670 was 
increased with the addition of GSH and NAC.  These results are plotted as mean+/- SD 
and representative of three separate experiments. (*=p<0.0001) (ckm040114 
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Figure 4.8: Supernatant from PAO1 cells decreases the survival of macrophage cells 
more than PW4670 supernatant.  
P. aeruginosa strains PW4670 and PAO1 were grown in YTA media for 30 hours at 
37°C with vigorous shaking.  Bacterial cells from both strains were removed through 
centrifugation to obtain a cell free supernatant.  The supernatants were diluted 1:3, 1:5, or 
1:10 in supplemented RPMI media.  The diluted supernatants were exposed to MHS cells 
that adhered to cell culture dishes for 24 hours.  Survival of macrophage cells was 
determined with trypan blue exclusion.  The survival of cells exposed to bacterial 
supernatants was compared the number of control cells exposed to the same dilution of 
YTA:RPMI to determine the percent survival.  This experiment was done in triplicate and 
is representative of three separate experiments.  Statistical significance was calculated 
with a two-tailed student’s T test *p<0.05. (kmp012414) 
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Figure 4.9
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Figure 4.9:  Supernatant from PAO1 is more lethal than PW4670 in a G. mellonella 
model.  P. aeruginosa strain PAO1 and PW4670 were grown in YTA media for 30 
hours.  Cell-free supernatant was obtained through centrifugation and injected into G. 
melonella larvae.  Death over the worms was recorded at 24 hours.  The data is depicted 
as an odds ratio, where 1 (dotted line) indicates no effect.   An odds ratio of three separate 
experiments with 9 worms per group was calculated and compared to a control injected 
with sterile YTA media (A) The average odds of death with the injection of PW4670 
supernatant compared to the control was  5.3 with an average p value of p=0.32, which 
does not indicate significance.  The average odds of death with PAO1 supernatant 
injection compared to the control was 31.2, with an average p  value of p=0.038, which 
indicates significance.  The three separate experiments were combined to increase the 
sample size and the PAO1 group was compared to the PW4670 injected group (B).   This 
comparison yielded an odds ratio of 7.48, which indicates death was 7.48 times more 
likely in the PA01 injected group than the PW4670 group.  The p value for this 
comparison was *p=0.0016, which indicates that this difference was significant. 
(kmp032714, 040114, 040214) B. Supernatants were dialyzed with 3,000-6,000 
molecular weight cut off dialysis membrane overnight and then injected into larvae the 
next morning.  After 24 hours of incubation neither the PAO1 or PW4670 dialyzed 
supernatants killed any of the larvae.  
 
   132
 
PAO1 PW4670
0.0
0.2
0.4
0.6
0.8
R
e
la
tiv
e
 
B
io
fil
m
 
Fo
rm
a
tio
n
*
PAO1 PW4670 PW4670+GSH
0.0
0.2
0.4
0.6
0.8
1.0
R
e
la
tiv
e
 
B
io
fil
m
 
Fo
rm
a
tio
n
*p=.001
*p=0.0015
p=0.35
A.
B.
   133
 
Figure 4.10: The absence of PmtA affects Biofilm Formation  
P. aeruginosa strains PW4670 and PAO1 overnight cultures were transferred to fresh 
YTA media in a 96 well plate, at a dilution of  1:10.  The plate was incubated in 37°C 
without shaking to allow the formation of a biofilm.  After 24 hours of growth, the 
growth yield of each well was measured with an absorbance reading at 595nm.   The 
media was aspirated from the wells and the remaining biofilm was fixed to the sides of 
the well.  The biofilm was then stained with 0.1% crystal violet for 40 minutes and 
subsequently removed from the wells.  Ethanol:acetone (4:1) was added to precipitate the 
crystal violet from the biofilm and the colorimetric change produced by the crystal violet 
stain was measured through an absorbance reading at 595nm.  The absorbance reading 
after the addition of crystal violet was divided by the growth yield absorbance readings to 
calculate the relative biofilm formation.  These results are the results for 3 separate 
experiments and  50 data points per strain.  Calculations of relative biofilm formation 
over 1.0 were excluded.  The data, plotted as mean +/- SD.  *p=0.0007 according to a 
Two-tailed Student’s T test.  B.) GSH at 10mM was added to the YTA media in the plate 
to determine if the addition of an antioxidant would rescue the biofilm formation.  GSH 
did not increase biofilm formation in the microtiter plate assay.  Calculations of relative 
biofilm formation over 1.0 were excluded from analysis.  The data is plotted as mean +/- 
SD, and p values were calculated using a two-tailed student’s T test.  Data is 
representative of 3 separate experiments. (avt030214, 030714, kmp032514) (avt032714, 
040114, 040414)  
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Figure 4.11 
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Figure 4.11: Expression of PmtA does not affect the growth of P. aeruginosa upon 
exposure to hydrogen peroxide. Both the wildtype PAO1 strain and PW4670 strains 
were grown overnight at 37°C with vigorous shaking by inoculating 5ml of YTA or YTA 
with tetracycline for PW4670 with a single colony from a streak plate.  Fresh YTA 
(50ml) without antibiotics was then inoculated with a 1:100 dilution of the overnight 
culture and grown for ~3 hours until the bacteria entered mid-log phase growth.  Each 
50ml culture was then split into to 25ml cultures, and one culture of each strain was 
exposed to 10mM H2O2.  Absorbance readings at 600nm were taken for ~4 hours after 
the addition of H2O2 and growth curves were plotted (A).  The growth of the two strains 
after the addition of H2O2 was compared to the untreated control flasks to calculate the 
percent of untreated control (B).  The percent of untreated control is plotted as the 
mean+/- SD from the means of three separate experiments.  The expression of PmtA did 
not alter the bacteria’s resistance to the oxidant H2O2. 
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4.3 Discussion 
  
 The expression of many virulence factors by the human pathogen P. aeruginosa 
vastly complicates the treatment of these infections.  In order to effectively treat the 
multi-drug resistant bacteria, an understanding of the functions of each virulence factor 
expressed by P. aeruginosa is extremely important.  The functions of the metallothionein 
PmtA expressed by P. aeruginosa in the context of virulence have not been previously 
studied.  The similarities of PmtA to its immunomodulatory mammalian MT counterpart 
suggest that PmtA can affect the redox environment in infection, and as a consequence 
affect P. aeruginosa virulence.  
 In this study, we have shown that a deficiency in the expression of PmtA results 
in a dramatic phenotypic difference in the production of the redox-active virulence factor 
pyocyanin.  Expression of pyocyanin is associated with the death of PMNs and 
macrophages,  which are the dominant immune cell types present in the immune response 
to P. aeruginosa infection [181, 279, 319-321].  The in vitro decrease in pyocyanin 
expression in the PmtA-deficient strain PW4670 suggests that this strain could be less 
able to kill immune cells and less able to establish a persistent infection than its parent 
strain counterpart.  Incubation of supernatants from the parent strain PAO1 and the 
PmtA-deficient PW4670 with MH-S alveolar macrophage cell line and subsequent 
measurement of survival shows that the supernatant from PAO1 can kill immune cells 
more efficiently than supernatants from PW4670 culture.  Resident alveolar macrophage 
cells are the first immune cells to encounter P. aeruginosa in a lung infection.  These 
cells are responsible for the production and release of cytokines and chemokines upon 
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contact with MAMPs.  They are essential to the host defense as they recruit other 
immune cells to the site of infection [176-178].  In this study we show that P. 
aeruginosa strain that lacks the expression of a functional PmtA protein is less likely to 
kill these critical immune cells in vitro.  This suggests that the strain that lacks PmtA, 
PW4670, would be less likely to interfere with the immune response from alveolar 
macrophage cells, and therefore less likely than its parent strain, PAO1, to perpetuate an 
infection. 
 In vivo studies used the Galleria mellonella moth larvae as a host to study the 
pathogenicity of the PAO1 and PW4670 supernatants.  The G. mellonella model was 
used because the innate immune system of insects is highly homologous to that of 
mammals [322]. The G. mellonella larvae show a high degree of resistance to microbial 
infections through both cellular and humoral defenses [322, 323].  This model therefore 
provides an accurate prediction of virulence prior to mammalian studies.  The 
studies done using this model indicate that the supernatant from PAO1 was more 
likely to kill the larvae than the supernatant from PW4670.  The supernatants from 
both PAO1 and PW4670 were also dialyzed using a 3,000 to 6,000 Dalton molecular 
weight cut off  dialysis membrane.  This size membrane would allow the pyocyanin 
to be filtered out of the supernatant, but retain slightly larger proteins, particularly 
PmtA.  When the supernatants were dialyzed, the PAO1 supernatant was no more 
likely to kill the larvae than the PW4670 supernatant.  This indicates that the 
pyocyanin is more likely to be the lethal factor in the PAO1 supernatant than the 
PmtA protein.  In the future, the lethal dose 50 (LD50) of both PW4670 and PAO1 
should be calculated in the larvae model to determine if the difference in the by 
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products of the supernatant translates to a difference in virulence.   It is likely that 
the PW4670 will be less virulent than PAO1 since mammalian models have shown 
that pyocyanin expression is necessary for the full virulence of P. aeruginosa [306]. 
 A decrease in the production of the redox-active metabolite pyocyanin affects the 
redox environment of the bacteria in a host.  Pyocyanin oxidizes NADPH and donates 
electrons to oxygen molecules to create ROS and prolong the persistence of harmful 
oxidants produced by PMNs and macrophages.  Though the ROS produced by immune 
cells are intended to kill the bacteria, oxidants are not specific to the bacteria and can 
potentially harm the host cells as well.  Additionally, pyocyanin decreases the expression 
of host defenses to ROS, such as the expression of catalases, which increases the 
likelihood of ROS-induced host cell death.  Our experiments suggest that PmtA 
expression is necessary for the production of pyocyanin, and therefore the lack of this 
MT would lessen the ability of the bacteria to manipulate the ROS response of the host.  
This would be a disadvantage to the bacteria, and again suggests that the PmtA-deficient 
strain PW4670 is less able to cause an infection than its parents strain PAO1.   
In addition, the prolonged persistence of the oxidant may be advantageous to the 
bacteria.  P. aeruginosa expresses and efflux pump that  serves to expel antibiotics from 
inside the bacterial cell to protect the cell from the effects of the antibiotic.  The negative 
regulator MexR controls the expression of the efflux pump [324].  In the absence of 
oxidant, MexR binds to the promoter region of the mexAB-oprM operon that encodes for 
the expression of the pump, and represses transcription.  In the presence of oxidant, two 
cysteine residues on MexR form a disulfide bond and the repressor no longer binds the 
promoter region.  This allows for transcription and expression of the efflux pump [325].  
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A decrease in extracellular oxidant as a result of the decrease in pyocyanin production 
may not push the formation of the MexR disulfide bond, and limit the expression of the 
efflux pump.  This may make the bacteria more susceptible to antibiotics.  In the absence 
of the oxidant pyocyanin, or in low levels of pyocyanin, the oxidant-sensitive signaling of 
MexR, may not become dysregulated, and leave the bacteria susceptible to the 
antibiotics. 
The absence of a functional PmtA protein also affects biofilm formation of P. 
aeruginosa.  In a biofilm, microbial cells alter their metabolic activity allowing the 
bacteria to adapt to new environments.  In a P. aeruginosa lung infection, the formation 
of a biofilm increases the likelihood that the patient will develop chronic P. aeruginosa 
infections [272].  Inhibition of biofilm formation is associated with a decrease in 
virulence in P. aeruginosa [326].   Since many of the metabolic shifts associated with 
biofilm formation are controlled through QS, it is also possible that the absence of a 
fully functional PmtA protein disrupts QS.  The few antibiotics that are able to kill P. 
aeruginosa must penetrate the biofilm in order to affect the growth of the pathogen.  
The conversion of to a mucoid-producing strain of bacteria, which usually happens 
upon biofilm formation and is regulated by QS, makes it extremely difficult for the 
antibiotic to reach the bacteria.  
It will be necessary in the future to complement the PW4670 strain in order 
to determine that the pyocyanin and biofilm-deficient phenotypes measured here 
can be contributed to the absence of PmtA.  The gene that encodes the PmtA protein 
may lie in an operon, which could complicate complementation.  If the gene is in an 
operon, the production of these other genes present in the operon should be 
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confirmed through PCR or western blot analysis.   The complementation of PW4670 
with PmtA is necessary to attribute the observed phenotypes to PmtA and not the 
other genes present in the operon.  
 The data collected in this study may be promising in the future treatment of P. 
aeruginosa. A treatment of P. aeruginosa that combines a decrease in pyocyanin 
production and biofilm production with antibiotics may represent a new type of 
therapeutic intervention.  The decrease in pyocyanin not only inhibits the ability of the 
pathogen to evade the immune response, but may also change redox-sensitive 
transcription elements in the bacteria that are responsible for the expression of the efflux 
pump.  PmtA represents a novel target to decrease the expression of pyocyanin and 
subsequently affect the pathogen’s susceptibility to antibiotic intervention.  The 
disruption the expression of a single protein, PmtA, may be an easier mechanism than the 
disruption of the several genes involved in the production of many different stages of 
pyocyanin expression.  This type of therapy that combines the targeting of a virulence 
factor with the administration of antibiotics may represent a new, innovative option in the 
treatment of the deadly human pathogen P. aeruginosa.   
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CHAPTER 5: CONCLUSIONS AND FUTURE DIRECTIONS 
 
 MTs represent a family of low molecular weight, cysteine rich proteins that use 
cysteine residues to associate with heavy metals [1].  MTs are evolutionarily conserved 
and are present in a diverse and extensive set of organisms [327].  The mammalian MT, 
specifically MT-I and MT-II, is the most extensively studied MT.  Among the many 
functions of this MT is the ability of the MT to influence the functions of immune cells, 
including proliferation, migration, and antibody response.   
 The interactions of MTs from other organisms with the mammalian immune 
system have not been studied until now.  A prokaryotic MT, known as PmtA, from the 
human pathogen P. aeruginosa may interact with immune cells during infection.  This 
studied aimed to determine if PmtA possesses similar immunomodulatory to mammalian 
MT, in particular PmtA’s influence over cell migration and overall virulence of the 
pathogen. 
 The effect of PmtA on Jurkat T cell chemotaxis was determined through the use 
of GST-PmtA purified from E. coli.  The Jurkat T cell model was used in order to 
compare the chemotactic effect of mammalian MT to that of PmtA, since it had been 
previously established that mammalian MT causes chemotaxis of this cell type [130].  
This cell type also lacks the TLR-4 receptor that responds to LPS, therefore any residual 
LPS from the purification of GST-PmtA would not affect the results of the study.  
Chemotaxis was measured in vitro with the conventional Boyden chamber assay as well 
as the innovative, real-time, automated ECIS/Taxis assay [135, 140].  Although GST-
PmtA did not cause chemotaxis of Jurkat T cells, GST-PmtA did block the migration of 
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cells in response to a known chemoattractant, SDF-1α.  GST-PmtA also disrupted the 
desensitization by internalization of the receptor SDF-1α receptor CXCR4.  This 
indicates that that PmtA does indeed influence the migration of immune cell in vitro.   
 The influence of PmtA on P. aeruginosa growth and virulence was determined 
with a comparison of a wildtype PAO1 strain and strain PW4670, in which a transposon 
interrupts the gene responsible for the transcription of PmtA. A comparison of the strains 
showed that pyocyanin production in strain PW4670 was severely inhibited.  The 
production of pyocyanin in PW4670 could be rescued with the addition of the anti-
oxidant glutathione.  This suggests that PmtA acts as an antioxidant in P. aeruginosa and 
the absence of this antioxidant decreases the ability of the organism to produce its redox-
sensitive virulence factor, pyocyanin.  This work is the first demonstration that the 
expression of an MT could affect the virulence of the human pathogen P. aeruginosa.    
 The capacity of PmtA to modulate the actions of immune cells and influence the 
expression of a virulence factor in a human pathogen leads to many new avenues of 
research.  PmtA modulates chemotaxis of immune cells differently from MT, in that it 
does not induce chemotaxis, but does block chemotaxis.  Recent studies out of our lab 
suggest that mammalian MT can also block chemotaxis of Jurkat T cells (not yet 
published).  It is therefore reasonable to hypothesize that PmtA may influence the 
functions of immune cells in other ways.  For example, mammalian MTs are known to 
increase the proliferation of T and B cells [56].  If PmtA increases the proliferation of 
both T and B cells it could be advantageous to the host in elimination of the infection by 
increasing the number of effector cells at the site of infection.  In contrast, it could cause 
the recruitment and proliferation of too many inflammatory cells to the site of infection 
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and cause damage to host tissues.  Proliferation of both B and T cells as a result of PmtA 
exposure could also result in immune dysregulation through polyclonal activation.  Both 
of these scenarios would suggest that PmtA could act as a immune modulator and 
influence the course of infection.   
 Since PmtA was not found on the outside of Jurkat T cell (Figure 3.10, 3.11), 
PmtA could be taken up by Jurkat T cells and affect cell signaling through interaction 
with intracellular components.  In addition, if PmtA can be found intracellularly, it could 
influence the redox status of the cell and alter redox-sensitive signaling.  Since it is 
known that H2O2 uptake is essential to the activation of Rho family GTPase and 
subsequent actin polymerization and migration in T cells, [244] a PmtA-induced change 
in the redox status of the cell is likely to affect a cell’s ability to migrate in response to 
chemokines.  In this case, PmtA may not be a specific inhibitor of cell movement, but a 
global inhibitor that can exert an inhibitory chemotactic effect on more than one 
chemokine-receptor axis or more than one immune cell type.  In order to determine if 
PmtA can affect the over all redox-status of the cell it will be necessary to measure the 
intracellular ROS in presence of PmtA with the redox sensitive probe H2DCFDA.  It 
would also be interesting to study PmtA’s ability to affect the movement of Jurkat T cells 
and other cell types in response to other chemokines.  This will determine if PmtA 
specifically exhibits a response on CXCR4 or if the response is a global response.   
 The ability of PmtA to effect the migration of immune cells coupled with the fact 
that its expression is necessary for the production of the virulence factor pyocyanin 
suggests that PmtA contributes to the overall virulence of P. aeruginosa.  Infection 
models can be used to determine if there is a difference in host survival between 
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organisms inoculated with wildtype strain PAO1 or PmtA-deficient strain PW4670.  A 
simple infection model uses Galleria mellonella larvae injected with various 
concentrations of both strains of P. aeruginosa.  In this model the survival of the larvae 
over time is recorded.  It will also be necessary to determine if there is a difference in 
virulence in a more complex mouse-model of infection.  In this model mice could be 
inoculated intranasally and the survival of mice inoculated with either PAO1 or PW4670 
would be recorded.  Additionally, bacterial burden in the lungs or in the broncho-alveolar 
fluid can be measured.  Histological staining of the lungs of mice infected would also 
determine if there is a difference in immune cell infiltration into the site of infection 
when a mouse is infected with either PAO1 or PW4670.  
 The decrease in pyocyanin production as a result of the absence of PmtA may 
make the bacteria more susceptible to antibiotic therapy than its wildtype counterpart.  
Through adaptations of the previously mention infection models, it could be determined 
if PmtA-deficient bacteria are more susceptible to antibiotic treatment.  Additionally, 
blocking the function of PmtA, with an PmtA-specific siRNA, coupled with antibiotic 
therapy could also influence the effectiveness of antibiotic intervention.  An PmtA-
specific antibody may not be effective as it would have to traverse the peptidoglycan 
layer of P. aeruginosa. It may be easier to disrupt a single gene, rather than the several 
genes involved pyocyanin production and biofilm production.   
 A continuation of the study of the functions of PmtA in context of infection could 
be vital to future treatments of P. aeruginosa infection.  If the addition of an PmtA-
specific siRNA blocks the function of this protein in vivo, it could represent a novel 
therapeutic intervention.  As more and more pathogens begin to acquire resistance to 
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antibiotics, new therapies must be developed so humans do no succumb to once-treatable 
infections.  Targeting of virulence factors and resistance mechanism, such as the P. 
aeruginosa efflux pump, to weaken bacteria is a potential new avenue to combat the 
ever-growing problem of bacterial resistance to antibiotics.  If targeting PmtA decreases 
the production of pyocyanin or changes the over redox-environment at the site of 
infection, it could decrease the virulence of the bacteria and allow antibiotics to penetrate 
the bacteria.  The implication of targeting a bacterial MT in the management of a 
bacterial infection represents potential novel and innovative approach to the treatment of 
antibiotic resistant human pathogens.   
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